Obesity

E4_OBESITY

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66 Cause of death: ICD-10 — E66 2 out of 7 registries used, show all original rules.	34132
4. Check minimum number of events None	34132
5. Include endpoints E4_OBESITYCAL E4_OBESITYDRUG E4_OBESITYXTRMALV E4_OBESITYNAS	35184
6. Filter based on genotype QC (FinnGen only)	33933

Control definitions (FinnGen only)

Control exclude: E4_OBESITY_HYPER

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E65-E68
Name in latin: Obesitas

NAME	E4_OBESITY
CONTROL_EXCLUDE	E4_OBESITY_HYPER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_OBESITYCAL\|E4_OBESITYDRUG\|E4_OBESITYXTRMALV\|E4_OBESITYNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E66
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E66
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	207520	122748	83494
Only index persons	188132	112943	75189
Unadjusted period prevalence (%)
Whole population	3.03	3.52	2.33
Only index persons	3.64	4.15	2.87
Median age at first event (years)
Whole population	48.54	46.90	50.95
Only index persons	47.74	45.65	50.87

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	33933	22654	11279
Unadjusted period prevalence (%)	7.08	8.04	5.17
Median age at first event (years)	50.59	47.97	55.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
35184: Matched controls
339373

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

323.0

2688

11816

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

322.8

7421

46013

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

321.3

3794

19115

I50

ICD-10 Finland

Heart failure

4.1

320.2

923

2238

ACC51

NOMESCO Finland

Release of median nerve

2.2

319.3

2800

12579

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.4

318.4

535

811

J46

ICD-10 Finland

Status asthmaticus

3.4

318.2

1182

3410

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

317.3

1615

5607

R03DC03

ATC

montelukast; oral

1.8

317.1

5961

34906

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

314.6

18218

140077

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

314.6

1918

7310

SPAT1240

SPAT

Therapeutic discussion

1.9

314.2

4238

22355

P03

ICPC

Feeling depressed

2.0

313.9

4030

20902

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

313.1

6209

36910

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

312.8

2652

11743

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

312.1

4108

21487

P01AB01

ATC

metronidazole; oral, rectal

1.5

311.7

13804

100105

C07AB02

ATC

metoprolol; systemic

1.8

311.4

5507

31653

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

309.8

8831

57794

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

7582

46860

L03

ICPC

Low back symptom/complaint

1.7

307.7

9829

62800

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

8225

49103

R60.0

ICD-10 Finland

Localized oedema

2.5

307.7

4614

19115

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

307.7

7991

35862

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.5

307.7

4595

19398

P76

ICPC

Depressive disorder

2.3

307.7

2848

12321

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

5754

26739

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.2

307.7

7545

36938

N05BA04

ATC

oxazepam; oral

1.7

307.7

8912

56625

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

307.7

6937

41263

E66.0

ICD-10 Finland

Obesity due to excess calories

519.2

307.7

1691

C09CA01

ATC

losartan; oral

1.8

307.7

7870

46693

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

307.7

3877

17489

L28

ICPC

Limited function/disability (L)

2.1

307.7

5644

27906

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8232

52093

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.8

307.7

5423

12316

SGA01

NOMESCO Finland

Emergency treatment

1.8

307.7

6166

36223

A10BD07

ATC

metformin and sitagliptin; systemic

3.5

307.7

1735

4917

E66.00

ICD-10 Finland

Metabolic syndrome

46.0

307.7

9636

2760

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

307.7

2568

10258

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

10403

68933

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

15620

99255

A08

ICPC

Swelling

3.1

307.7

1874

6041

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

4826

22326

K02.1

ICD-10 Finland

Caries of dentine

1.6

307.7

21369

165347

XG466

NOMESCO Finland

Sleep oxymetry

6.2

307.7

1846

3018

G47.3

ICD-10 Finland

Sleep apnoea

5.7

307.7

15371

40530

103

Kela drug reimbursment

Diabetes, insulin-treated

4.3

307.7

13892

44288

A10AE04

ATC

insulin glargine; parenteral

3.8

307.7

4818

13554

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

307.7

7114

36944

A10AC01

ATC

insulin (human); parenteral

3.5

307.7

3446

10221

J01AA02

ATC

doxycycline; systemic

1.8

307.7

26592

216248

N02BE01

ATC

paracetamol; systemic, rectal

2.8

307.7

31936

265096

C09AA05

ATC

ramipril; oral

1.8

307.7

6939

41069

Z3226

NOMESCO Finland

Physiotherapist

1.9

307.7

6179

34607

B01AA03

ATC

warfarin; systemic

2.0

307.7

5030

25622

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.1

307.7

1650

3274

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

307.7

16297

109818

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

307.7

9864

45100

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

307.7

4170

18782

C07AB07

ATC

bisoprolol; oral

2.0

307.7

16036

98836

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.6

307.7

4939

5656

A10BJ01

ATC

exenatide; parenteral

13.3

307.7

803

596

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

307.7

4281

19220

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

307.7

9451

61318

160

Kela drug reimbursment

exenatide

18.7

307.7

1961

1067

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

307.7

4249

20085

B03BA03

ATC

hydroxocobalamin; parenteral

3.0

307.7

1886

6335

A10BB01

ATC

glibenclamide; oral

4.1

307.7

1083

2623

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

307.7

5446

29102

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.2

307.7

800

1520

N06AX16

ATC

venlafaxine; oral

2.2

307.7

6226

29812

T83

ICPC

Overweight

5.2

307.7

1344

2561

SPAT1254

SPAT

Administration of medicine

2.0

307.7

4794

25205

M10.9

ICD-10 Finland

Gout, unspecified

3.3

307.7

2560

7789

J01MA12

ATC

levofloxacin; systemic

1.8

307.7

5811

33124

R03BA05

ATC

fluticasone; inhalant

1.8

307.7

6608

37996

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

307.7

6352

20012

C10AA05

ATC

atorvastatin; oral

1.7

307.7

12171

81938

S76

ICPC

Skin infection other

2.7

307.7

1961

7370

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.8

307.7

1587

4120

C09DA01

ATC

losartan and diuretics; oral

2.2

307.7

3464

16077

N05AH04

ATC

quetiapine; oral

2.1

307.7

7093

36784

N05AX12

ATC

aripiprazole; systemic

3.0

307.7

1869

6273

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.5

307.7

1006

1793

SPAT1310

SPAT

Counselling related to known health issue

1.7

307.7

10932

72257

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

307.7

1803

6372

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1856.0

307.7

890

J01FA06

ATC

roxithromycin; oral

1.6

307.7

13287

94070

L15

ICPC

Knee symptom/complaint

1.9

307.7

8480

48801

A10AE05

ATC

insulin detemir; parenteral

3.4

307.7

2353

7062

205

Kela drug reimbursment

Chronic hypertension

2.8

307.7

9533

40096

A10BH05

ATC

linagliptin; oral

3.7

307.7

1902

5153

162

Kela drug reimbursment

liraglutide

18.6

307.7

1030

550

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

9106

57434

A08AA62

ATC

bupropion and naltrexone; systemic

14.1

307.7

464

321

N06AX21

ATC

duloxetine; oral

2.3

307.7

4949

22281

207

Kela drug reimbursment

Chronic arrhythmias

2.0

307.7

4002

20489

R03BA02

ATC

budesonide; inhalant

1.8

307.7

6301

36545

T82

ICPC

Obesity

13.4

307.7

4799

3961

C03CA01

ATC

furosemide; systemic

3.4

307.7

11662

42802

N06AB03

ATC

fluoxetine; oral

2.2

307.7

4923

23120

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.5

307.7

6974

22523

3055, ,

Kela drug reimbursment

14.5

307.7

437

295

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.0

307.7

7459

41029

A10BK03

ATC

empagliflozin; oral

4.2

307.7

5005

13025

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

307.7

5004

24651

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.3

307.7

3379

15092

N03AX16

ATC

[U] pregabalin

2.0

307.7

8534

47013

XX_20

NOMESCO Finland

Bioimpedance measurement

32.4

307.7

230

WX780

NOMESCO Finland

Remote monitoring CPAP

3.7

307.7

2105

5766

M04AA01

ATC

allopurinol; systemic

3.3

307.7

5041

16382

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.1

307.7

4261

14333

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

10816

72612

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

11250

76572

B01AB05

ATC

enoxaparin; parenteral

2.3

307.7

12300

64252

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

10356

51687

C10AA01

ATC

simvastatin; oral

1.8

307.7

11959

74822

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.7

307.7

1505

2658

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

307.7

3399

16057

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

6192

36354

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.2

307.7

727

996

R06.5

ICD-10 Finland

Mouth breathing

2.3

307.7

3481

15165

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

22.1

307.7

1097

493

A08AB01

ATC

orlistat; oral

25.0

307.7

668

263

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.8

307.7

5607

21355

SPAT1263

SPAT

Sampling

1.6

307.7

14669

102826

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

307.7

1973

7475

A10BX04

ATC

[U] exenatide

20.1

307.7

936

460

I10

ICD-10 Finland

Essential (primary) hypertension

2.9

307.7

22213

126365

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

307.7

5480

27309

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

307.7

2129

8124

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

307.7

3648

16817

I50.9

ICD-10 Finland

Heart failure, unspecified

3.2

307.7

4451

14622

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.0

307.7

8058

23358

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.6

307.7

5241

21633

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.2

307.7

1267

2428

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

307.7

4741

19569

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

25772

204469

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2977.7

307.7

3097

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

2949

12174

QBJ30

NOMESCO Finland

Correction of abdominal apron

32.8

307.7

1039

315

A10BJ06

ATC

semaglutide; parenteral

9.0

307.7

4282

5150

3051, ,

Kela drug reimbursment

12.4

307.7

912

727

A10BK01

ATC

dapagliflozin; oral

4.0

307.7

3481

9130

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

4902

18632

C02AC05

ATC

moxonidine; oral

3.5

307.7

1729

5004

A10BH01

ATC

sitagliptin; oral

4.4

307.7

4873

11902

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.2

307.7

3190

14469

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

21587

144216

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

307.7

2684

11072

EBA00

NOMESCO Finland

Extraction of tooth

1.6

307.7

12520

85730

WX723

NOMESCO Finland

CPAP therapy

3.5

307.7

1914

5486

I50.0

ICD-10 Finland

Congestive heart failure

3.5

307.7

2238

6535

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.8

307.7

1850

6529

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

14560

104891

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

307.7

4747

23057

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

10140

61476

A08AA10

ATC

sibutramine; oral

22.5

307.7

340

147

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

307.7

10841

57778

J01DA01

ATC

[U] cefalexin

1.7

307.7

21531

164504

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.8

307.7

914

1890

R4190

NOMESCO Finland

Nutritional therapy

5.6

307.7

2485

4526

A08AA02

ATC

fenfluramine; oral

8.3

307.7

520

611

H02AB06

ATC

prednisolone; systemic

1.8

307.7

16959

114221

WX290

NOMESCO Finland

Other blockage of nerve

1.7

307.7

17589

127901

358

Kela drug reimbursment

liraglutide

18.2

307.7

432

232

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

307.7

7372

42432

OAB72

NOMESCO Finland

Weight control and weight loss guidance

25.6

307.7

965

374

N06AB10

ATC

escitalopram; oral

1.7

307.7

7907

48275

E66.8

ICD-10 Finland

Other obesity

169.2

307.7

12819

1146

A10BB12

ATC

glimepiride; oral

4.4

307.7

2777

6436

T90

ICPC

Diabetes non-insulin dependent

4.1

307.7

12176

38723

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

307.7

13090

90980

E66

ICD-10 Finland

Obesity

13.1

307.7

6296

5558

OAB72, ,

SPAT

7.5

307.7

816

1076

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

307.7

3289

15626

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

15533

104359

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.5

307.7

4693

19527

P06

ICPC

Sleep disturbance

2.0

307.7

4589

23362

C03AA03

ATC

hydrochlorothiazide; oral

2.8

307.7

3136

11481

C09AA02

ATC

enalapril; systemic

2.2

307.7

6187

29746

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

3419

10930

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.8

307.7

1956

7068

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

24153

177805

A10BG03

ATC

pioglitazone; oral

5.6

307.7

1240

2187

C08CA13

ATC

lercanidipine; oral

2.2

307.7

4608

22010

M54.5

ICD-10 Finland

Low back pain

1.8

307.7

13622

86613

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.2

307.7

2671

4466

N06AX12

ATC

bupropion; oral

2.5

307.7

3345

13600

J96.1

ICD-10 Finland

Chronic respiratory failure

6.5

307.7

953

1444

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

13729

96661

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.2

307.7

3826

5640

C08CA01

ATC

amlodipine; oral

2.0

307.7

12419

71512

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

9268

58801

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

307.7

6569

37340

A10BJ05

ATC

dulaglutide; parenteral

8.8

307.7

1459

1663

A10BJ02

ATC

liraglutide; parenteral

14.0

307.7

2952

2209

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

307.7

5397

26239

A46

ICD-10 Finland

Erysipelas

3.0

307.7

6126

22503

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

15300

101345

J01DB01

ATC

cefalexin; oral

2.3

307.7

30067

245304

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

307.7

3489

14952

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.7

307.7

1218

2586

N03AX12

ATC

[U] gabapentin; oral

2.0

307.7

5756

30937

S97

ICPC

Chronic ulcer skin

3.3

307.7

2284

7032

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

307.7

7060

37930

A10BA02

ATC

metformin; oral

5.4

307.7

16296

46879

E66.01

ICD-10 Finland

Obesity due to excess calories

110.3

307.7

20318

4153

SPAT1262

SPAT

Handing over of treatment supplies

3.3

307.7

8140

28743

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.2

307.7

1264

3010

E66.9

ICD-10 Finland

Obesity, unspecified

97.0

307.7

7124

886

N06AB04

ATC

citalopram; systemic

2.0

307.7

7888

43085

R5140

NOMESCO Finland

Monitoring the use of the aid

4.9

307.7

6845

16048

J45

ICD-10 Finland

Asthma

2.1

307.7

3900

19191

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.9

307.7

5362

6036

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

16671

97497

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.7

307.7

1547

4171

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.5

307.7

4433

18845

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

307.7

1030

A10BX07

ATC

[U] liraglutide

19.7

307.7

1207

610

R03BB04

ATC

tiotropium bromide; inhalant

2.4

307.7

3226

13798

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.3

307.7

869

1985

WX722

NOMESCO Finland

PEEP

5.2

307.7

2497

4953

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

307.7

854

RD210, ,

NOMESCO Finland

7.4

307.7

1229

1661

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

307.7

1323

3847

S18

ICPC

Laceration/cut

1.6

307.7

14898

104533

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

307.7

10401

65274

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

307.7

3241

13936

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.2

307.7

13108

41711

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.1

307.7

13150

35646

C03DA01

ATC

spironolactone; oral

3.0

307.7

4694

16622

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

307.7

19635

150119

C09BA02

ATC

enalapril and diuretics; systemic

2.6

307.7

2552

9883

J01FF01

ATC

clindamycin; systemic

2.0

307.7

10434

58708

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

431.1

307.7

1661

E66.1

ICD-10 Finland

Drug-induced obesity

92.5

307.7

389

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

306.2

7616

48123

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

306.1

16530

124933

A28

ICPC

Limited function/disability NOS

1.9

305.6

4332

23218

N06AB06

ATC

sertraline; oral

1.9

304.1

4280

22881

N06AX11

ATC

mirtazapine; oral

1.6

302.4

11336

79070

M03BX02

ATC

tizanidine; oral

1.5

302.1

21637

173376

SPAT1139

SPAT

Nutrition survey

3.2

301.3

1261

3915

M10

ICD-10 Finland

Gout

2.9

301.3

1465

4959

M01AB05

ATC

diclofenac; systemic, rectal

1.5

301.0

22402

180921

N03AX09

ATC

lamotrigine; oral

2.5

300.9

2068

8343

K07

ICPC

Swollen ankles/oedema

2.9

300.0

1452

4902

K04.0

ICD-10 Finland

Pulpitis

2.0

299.8

3692

18855

ZXD05

NOMESCO Finland

Urgent procedure

1.6

297.8

10155

69255

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

297.6

4454

24282

C09DA06

ATC

candesartan and diuretics; oral

2.3

295.8

2491

10991

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

295.3

6983

43484

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

295.2

5329

30773

M01AE02

ATC

naproxen; oral, rectal

1.5

293.3

19544

153778

SFA30

NOMESCO Finland

Three-surface restoration

1.5

292.3

14201

104611

T07

ICPC

Weight gain

4.4

289.9

751

1679

N05AA02

ATC

levomepromazine; systemic

2.8

288.9

1496

5239

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

286.4

1284

4150

SPAT1301

SPAT

No procedures

1.6

286.1

9993

68399

C09CA06

ATC

candesartan; oral

1.6

284.7

7676

49378

A10AD05

ATC

insulin aspart; parenteral

5.2

284.5

605

1148

SFA20

NOMESCO Finland

Two-surface restoration

1.5

284.5

20516

163591

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

284.5

2515

11317

A10BX01

ATC

guar gum; oral

3.3

284.3

1131

3404

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

282.9

2297

9974

M01AH05

ATC

etoricoxib; oral

1.5

282.9

21011

168462

M79.7

ICD-10 Finland

Fibromyalgia

2.8

282.7

1502

5331

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.2

282.6

784

1847

N05CF01

ATC

zopiclone; oral

1.6

282.5

9802

66949

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

282.3

4151

22474

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.0

282.2

818

1991

S10

ICPC

Boil/carbuncle

2.4

282.1

2119

8894

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

281.0

1649

6160

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

280.8

4758

26924

M10.0

ICD-10 Finland

Idiopathic gout

3.3

277.8

1116

3379

B01AB04

ATC

dalteparin; parenteral

2.5

277.6

1851

7357

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.8

277.3

1449

5097

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

276.5

11372

80583

R03AC03

ATC

terbutaline; inhalant

1.8

276.2

4778

27197

M48.0

ICD-10 Finland

Spinal stenosis

2.0

275.2

3488

17964

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

274.9

6358

39268

R06AE07

ATC

cetirizine; oral

1.5

274.8

15213

114649

A10BG02

ATC

rosiglitazone; oral

5.5

273.7

536

944

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

273.3

4346

24103

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

273.3

5865

35497

SPAT1229

SPAT

Assessment of need for aid

2.3

273.0

2289

10071

W85

ICPC

Gestational diabetes

2.6

272.9

1698

6527

W84

ICPC

Pregnancy high risk

2.7

271.0

1544

5680

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

270.9

3646

19159

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

270.7

8382

55655

R96

ICPC

Asthma

2.0

270.5

3244

16382

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

6.0

270.4

488

795

A02BC01

ATC

omeprazole; systemic

1.6

268.4

8574

57329

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

268.2

23721

196008

C01DA14

ATC

isosorbide mononitrate; oral

2.0

267.4

3446

17839

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

267.0

3662

19359

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

266.2

11462

81858

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

264.9

4127

22728

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

6.0

264.7

473

763

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

264.5

3783

20273

SFA10

NOMESCO Finland

One-surface restoration

1.5

264.1

18974

150129

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

263.9

17818

139264

J20

ICD-10 Finland

Acute bronchitis

1.9

263.2

3598

18995

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

262.8

8437

56432

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.0

262.1

762

1858

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

261.6

4174

23153

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

261.3

3474

18167

A10BD03

ATC

metformin and rosiglitazone; systemic

5.1

261.2

556

1056

B01AF02

ATC

apixaban; oral

2.0

261.2

3292

16906

AA40B, ,

NOMESCO Finland

9.8

260.8

308

307

Z71.8

ICD-10 Finland

Other specified counselling

1.5

256.6

10602

74917

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

256.1

8819

59879

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

253.9

11051

78911

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

253.8

2444

11364

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.5

252.4

1726

6935

R01AD09

ATC

mometasone; nasal

1.5

250.3

15738

120837

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

249.6

4345

24720

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.0

248.6

735

1814

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.7

248.4

1398

5108

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

247.3

25156

211819

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.3

247.3

648

1461

A10BH02

ATC

vildagliptin; oral

4.2

246.6

676

1578

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

246.5

3855

21224

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.0

246.0

1158

3845

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.4

245.8

917

2650

H3600, E113,

ICD-10 Finland

5.7

244.9

467

802

C09CA03

ATC

valsartan; oral

2.0

244.7

2747

13527

B81

ICPC

Anaemia vit B12/folate deficiency

2.9

244.2

1178

3965

R4110

NOMESCO Finland

Physiotherapy

1.6

244.2

8556

58211

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

243.8

8277

55911

K04.08

ICD-10 Finland

Other specified pulpit

2.0

243.8

2902

14593

L16

ICPC

Ankle symptom/complaint

1.8

242.3

3841

21230

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

241.3

2684

13169

N02AA05

ATC

oxycodone; systemic

1.7

241.0

4703

27635

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.4

239.2

479

861

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.8

238.7

441

735

N06AA09

ATC

amitriptyline; systemic

2.0

238.3

2981

15247

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

238.0

8979

62021

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

236.8

2734

13593

L90

ICPC

Osteoarthrosis of knee

2.3

235.7

2013

8911

A06AD11

ATC

lactulose; oral

1.8

235.6

3869

21605

SPAT1260

SPAT

Consultation of another employee

1.7

235.2

5661

35171

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

234.2

2412

11497

N02BF01

ATC

gabapentin; oral

2.0

233.5

2728

13619

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.7

233.2

545

1121

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

49.5

231.9

138

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.2

231.3

2054

9237

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

231.0

7746

52079

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

7.7

230.2

327

412

H02AB07

ATC

prednisone; oral

1.8

229.3

4235

24472

SPAT1211

SPAT

Application of soft bandage

2.0

228.7

2787

14117

C08CA02

ATC

felodipine; oral

2.1

228.7

2499

12174

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.6

228.7

773

2094

J01MA02

ATC

ciprofloxacin; systemic

1.5

228.5

11773

86524

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

228.1

2674

13360

M02AA07

ATC

piroxicam; topical

1.5

228.1

10583

76176

SPAT1283

SPAT

Restricted health certificate

1.6

227.2

6739

44025

R53

ICD-10 Finland

Malaise and fatigue

1.6

226.8

7709

51953

A01

ICPC

Pain general/multiple sites

1.9

226.6

2918

15062

A12BA01

ATC

potassium chloride; oral

3.0

225.1

1064

3539

J01CF05

ATC

flucloxacillin; systemic

2.2

223.4

2109

9716

R03BA01

ATC

beclometasone; inhalant

1.7

223.2

4461

26341

OAB50, ,

SPAT

2.3

221.2

1814

7890

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

221.2

4037

23231

S80.0

ICD-10 Finland

Contusion of knee

2.0

221.1

2634

13231

SPAT1312

SPAT

General health counselling

1.5

220.5

10444

75374

F34.1

ICD-10 Finland

Dysthymia

2.5

219.7

1428

5597

A10BX09

ATC

[U] dapagliflozin

5.8

218.6

409

690

R03DA04

ATC

theophylline; systemic, rectal

2.5

218.2

1394

5419

N02BF02

ATC

pregabalin; oral

2.2

217.9

2039

9358

R05

ICPC

Cough

1.5

217.7

7799

53097

R51.80

ICD-10 Finland

Headache

1.6

217.4

5406

33796

D11

ICPC

Diarrhoea

1.7

217.4

4193

24503

N05BA01

ATC

diazepam; systemic, rectal

1.8

217.2

3996

23040

J01FA09

ATC

clarithromycin; systemic

1.5

213.9

10318

74628

WZC30

NOMESCO Finland

Teaching

1.7

213.8

4816

29343

J01CA04

ATC

amoxicillin; systemic

1.5

213.7

28222

245900

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

13.3

213.1

205

149

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

212.0

1093

3811

N05AX08

ATC

risperidone; systemic

2.0

211.2

2381

11720

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

208.4

12416

93350

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.7

208.4

4289

25496

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

208.3

3114

16856

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

208.3

7749

53106

H02AB04

ATC

methylprednisolone; systemic

1.7

208.1

4511

27192

N62

ICD-10 Finland

Hypertrophy of breast

2.4

207.7

1550

6469

H3601, E113,

ICD-10 Finland

4.6

207.6

506

1077

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

207.6

4981

30825

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

207.3

4000

23356

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

206.6

2464

12370

D07AC01

ATC

betamethasone; topical

1.4

206.5

11323

83795

SPAT1255

SPAT

Intravenous administration of medicine

2.1

205.2

2109

10030

C07AG02

ATC

carvedilol; oral

2.3

205.0

1587

6730

R5110, ,

SPAT

2.2

204.6

1913

8772

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

203.2

1615

6926

WX402

NOMESCO Finland

General anaesthesia

1.5

201.9

6899

46377

N05CD07

ATC

temazepam; oral

1.8

201.3

3065

16677

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

201.2

2498

12713

RD112, ,

NOMESCO Finland

12.9

200.9

197

148

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

200.5

8921

63341

C01AA05

ATC

digoxin; systemic

2.3

199.9

1653

7208

L60.0

ICD-10 Finland

Ingrowing nail

2.3

199.8

1608

6933

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

198.0

1208

4590

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

197.7

4254

25565

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.4

197.6

1365

5501

F50.8

ICD-10 Finland

Other eating disorders

7.3

197.1

294

392

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.2

196.2

527

1211

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

196.0

4257

25641

D01AC02

ATC

miconazole; topical

2.0

195.8

2243

11096

M54

ICD-10 Finland

Dorsalgia

1.7

194.5

4232

25498

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

194.2

1731

7784

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

194.2

1187

4514

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

193.8

7660

53040

B01AF01

ATC

rivaroxaban; oral

1.8

193.4

3351

18948

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

193.4

2985

16303

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

193.3

3206

17897

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

192.4

813

2534

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

192.1

2177

10725

UJF32

NOMESCO Finland

Coloscopy

1.5

191.6

7525

52017

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

191.5

2658

14034

R06.2

ICD-10 Finland

Wheezing

2.3

191.0

1527

6562

B01AB10

ATC

tinzaparin; parenteral

1.8

189.8

3082

17089

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

189.8

5316

34098

C09DA03

ATC

valsartan and diuretics; oral

2.4

189.8

1419

5924

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

187.8

2843

15427

WX320

NOMESCO Finland

Spinalanesthesy

1.5

187.7

7188

49399

C10AA07

ATC

rosuvastatin; oral

1.5

187.0

9032

64995

S29

ICPC

Skin symptom/complaint other

1.6

185.7

5748

37713

N18.8

ICD-10 Finland

Other chronic renal failure

3.2

185.4

741

2233

E0000UV, ,

ATC

1.4

184.8

13443

104044

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

184.1

2974

16459

SPAT1216

SPAT

Assessment of functional ability

1.7

183.7

4010

24156

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

183.7

1077

4011

XA420

NOMESCO Finland

Extensive sleep examination

4.4

182.6

469

1041

A02BC05

ATC

esomeprazole; systemic

1.4

182.5

12625

96816

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

182.5

12337

94235

K08.3

ICD-10 Finland

Retained dental root

2.0

182.0

2291

11702

I50.1

ICD-10 Finland

Left ventricular failure

2.5

181.9

1169

4552

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

181.9

3862

23092

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.0

181.3

830

2710

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.4

180.0

666

1913

RD140, ,

NOMESCO Finland

79.8

179.9

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

179.9

3030

16974

WX002

NOMESCO Finland

Sedation and analgesia

1.6

179.5

5525

36171

M01AH01

ATC

celecoxib; oral

1.6

178.7

5252

34021

N06AX26

ATC

vortioxetine; oral

1.9

178.2

2586

13838

N06AX03

ATC

mianserin; oral

2.3

178.2

1499

6579

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

177.8

2213

11257

P99

ICPC

Psychological disorders other

2.5

177.5

1129

4374

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.0

176.3

508

1230

R74

ICPC

Upper respiratory infection acute

1.4

175.9

11222

84725

A02BC03

ATC

lansoprazole; oral

1.5

175.9

8347

59735

A03

ICPC

Fever

1.5

173.4

5772

38422

SGC10

NOMESCO Finland

Pulp capping

1.8

173.1

3124

17845

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

173.0

724

2243

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

171.7

933

3342

P29

ICPC

Psychological sympt/compl other

1.9

171.2

2508

13454

N05AF03

ATC

chlorprothixene; systemic

2.7

171.1

956

3474

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

171.0

2217

11431

L30.4

ICD-10 Finland

Erythema intertrigo

3.7

169.2

540

1406

F32

ICD-10 Finland

Depressive episode

2.0

169.2

2016

10097

N05AN01

ATC

lithium; oral

2.7

168.2

915

3279

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

167.1

6933

48265

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.9

167.1

795

2652

Z2446

NOMESCO Finland

Social worker

2.0

165.9

2051

10403

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

165.5

2665

14713

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

164.0

4492

28574

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.7

163.7

893

3205

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

163.7

3780

23059

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

163.4

3244

19016

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

163.1

7474

53006

R32

ICD-10 Finland

Unspecified urinary incontinence

2.8

162.8

841

2933

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

162.7

3612

21811

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

162.6

945

3503

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

162.4

1500

6833

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

161.5

4468

28478

J01DA09

ATC

[U] cefadroxil

1.4

161.0

8379

60823

E65

ICD-10 Finland

Localized adiposity

21.5

160.1

122

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

159.0

6564

45591

J01FA10

ATC

azithromycin; systemic

1.4

158.8

19441

161949

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.3

158.7

420

954

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

158.7

1072

4271

A10AE06

ATC

insulin degludec; parenteral

2.4

158.6

1157

4773

N19

ICD-10 Finland

Unspecified kidney failure

2.7

158.6

893

3257

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

158.6

3581

21710

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

158.5

1980

10074

M01AX05

ATC

glucosamine; oral

1.6

158.4

4734

30703

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

158.4

748

2484

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

158.1

2503

13742

J45.8

ICD-10 Finland

Mixed asthma

2.5

158.1

1011

3926

M01AX17

ATC

nimesulide; oral

1.5

157.9

6554

45561

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.3

157.5

1199

5040

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

156.3

3011

17493

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

156.0

8438

61614

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

154.9

6179

42593

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

154.9

604

1793

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

154.7

2641

14825

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

154.6

2585

14421

AN1

Coronary angiography

1.8

154.6

2519

13947

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

154.3

1643

7898

M01AB01

ATC

indometacin; systemic, rectal

2.0

154.2

1866

9388

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

153.9

1936

9870

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

153.2

2544

14164

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

153.1

3555

21695

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

152.8

760

2597

ZY010

NOMESCO Finland

Hospital outpatient

2.0

152.8

1761

8711

A10BD20

ATC

metformin and empagliflozin; oral

3.7

152.7

495

1303

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

152.2

2140

11317

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

151.7

679

2188

SPAT1234

SPAT

Support of social functional capacity

2.2

151.5

1351

6066

L14

ICPC

Leg/thigh symptom/complaint

1.8

151.4

2329

12668

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

151.0

1698

8325

A10AB06

ATC

insulin glulisine; parenteral

4.3

150.9

400

910

J96.0

ICD-10 Finland

Acute respiratory failure

4.3

150.7

400

911

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

150.6

1207

5186

R04

ICPC

Breathing problem other

2.3

149.4

1199

5155

R03AC13

ATC

formoterol; inhalant

2.1

148.2

1480

6945

H01

ICPC

Ear pain/earache

1.6

148.2

3802

23769

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

147.7

13596

108045

R03AC12

ATC

salmeterol; inhalant

2.2

147.1

1253

5522

SPAT1377

SPAT

Polysomnography

2.4

146.9

1099

4584

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

146.4

1424

6615

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.0

146.3

429

1052

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

146.2

22725

194986

M01AC06

ATC

meloxicam; systemic, rectal

1.4

145.9

10732

82335

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

145.4

11211

86634

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

145.2

5440

36971

N05AH03

ATC

olanzapine; systemic

1.9

145.1

2005

10539

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

145.1

4695

30938

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.8

144.8

445

1129

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.6

144.3

884

3362

A04

ICPC

Weakness/tiredness general

1.6

144.0

4378

28456

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.4

143.6

523

1487

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.0

143.2

653

2126

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

143.2

3439

21143

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.4

143.0

989

3982

N03AG01

ATC

valproic acid; systemic, rectal

1.9

142.6

1878

9717

D07AC13

ATC

mometasone; topical

1.4

142.5

8768

65277

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

142.5

726

2513

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

142.3

8695

64655

N06AX05

ATC

trazodone; oral

2.5

142.2

904

3499

ZXA00

NOMESCO Finland

Right side

1.4

142.0

7081

50818

SPAT1104

SPAT

Monitoring of emergency patient

1.9

141.8

1863

9631

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

141.8

9253

69553

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

141.6

5756

39743

C03BA11

ATC

indapamide; oral

2.7

141.5

782

2825

N05AB03

ATC

perphenazine; systemic, rectal

2.3

141.2

1115

4760

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

141.1

1180

5160

J01MA14

ATC

moxifloxacin; systemic

1.7

140.9

2550

14540

CL2S4, ,

SPAT

3.4

140.8

513

1459

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

140.8

1160

5041

R11

ICD-10 Finland

Nausea and vomiting

1.7

140.5

2602

14933

R01AD08

ATC

fluticasone; nasal

1.4

140.5

9170

68910

SPAT1281

SPAT

Other administrative function

1.8

140.5

2398

13446

AA1AD

NOMESCO Finland

CT of head and brain

1.4

139.3

7082

50979

C10AB05

ATC

fenofibrate; oral

3.1

139.1

593

1857

40199

ICD-8 Finland

Essential benign hypertension

3.7

138.8

457

1216

E000001, ,

ATC

1.5

138.4

6142

43110

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

138.2

952

3825

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

138.2

2026

10849

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

137.7

612

1964

SPAT1097

SPAT

Recording of ECG

1.6

137.6

3820

24301

J02AC01

ATC

fluconazole; systemic

1.3

137.5

13163

104864

L86

ICPC

Back syndrome with radiating pain

1.9

137.3

1835

9538

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

137.1

2640

15313

L08

ICPC

Shoulder symptom/complaint

1.4

137.1

6340

44836

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

136.8

2963

17733

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

136.1

8939

67175

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

136.0

1739

8907

C02EA02, ,

ATC

2.5

136.0

913

3626

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

135.6

1675

8480

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

135.2

1321

6144

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.2

135.2

555

1700

SPAT1054

SPAT

Examination of peripheral nervous system

3.2

134.8

539

1625

K77

ICPC

Heart failure

3.3

134.6

519

1530

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

134.4

1310

6087

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

133.9

3478

21772

SPAT1058

SPAT

PEF monitoring instruction

1.8

133.9

2343

13226

M79.1

ICD-10 Finland

Myalgia

1.5

133.9

4572

30433

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

133.6

783

2913

ZXE00

NOMESCO Finland

One hour or less

1.3

133.3

11880

93525

SPAT1153

SPAT

Removal of sutures

1.4

133.0

8818

66320

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

133.0

835

3213

R50.9

ICD-10 Finland

Fever, unspecified

1.5

132.9

4370

28851

C08DB01

ATC

diltiazem; oral

2.2

132.6

1114

4880

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

132.3

1779

9263

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

132.1

3106

18974

R42

ICD-10 Finland

Dizziness and giddiness

1.4

131.9

6311

44867

G44.2

ICD-10 Finland

Tension-type headache

1.5

131.9

4419

29287

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

131.2

768

2856

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

131.1

2433

13961

EBA30

NOMESCO Finland

Extraction of root of tooth

2.0

130.7

1579

7931

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

130.5

562

1771

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

130.4

2392

13682

A08AA01

ATC

phentermine; oral

7.2

130.3

195

261

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

129.7

4475

29834

C10AX09

ATC

ezetimibe; oral

1.5

129.6

4047

26411

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

129.2

2811

16832

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.2

129.2

1131

5038

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

129.0

1636

8354

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.3

128.9

1042

4491

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.6

128.8

3227

20017

R4110, ,

SPAT

1.7

128.6

2450

14158

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.1

127.7

272

517

D07XC01

ATC

betamethasone; topical

1.6

127.6

3386

21290

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

127.0

1700

8836

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

126.9

1163

5276

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

126.7

1595

8124

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

126.7

1642

8445

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

126.3

1198

5507

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

126.3

11213

88039

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

126.3

2159

12100

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.7

125.8

712

2603

M09AX01

ATC

hyaluronic acid; parenteral

2.2

125.3

1156

5257

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.8

125.2

1854

9951

C09CA07

ATC

telmisartan; oral

1.8

124.9

2007

11044

KGH10

NOMESCO Finland

Operation for phimosis

2.7

124.9

707

2585

R52.9

ICD-10 Finland

Pain, unspecified

1.6

124.6

2950

18041

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.9

124.3

599

2012

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

124.2

1126

5085

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

123.7

1315

6310

K04.09

ICD-10 Finland

Pulpit UNS

1.9

123.6

1534

7774

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

123.4

872

3544

ZXA05

NOMESCO Finland

Left side

1.4

123.4

6496

46908

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

123.0

7781

57941

L68.0

ICD-10 Finland

Hirsutism

4.4

122.8

310

679

N05BA12

ATC

alprazolam; oral

1.6

122.8

2896

17689

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

122.7

1206

5620

G04BD12

ATC

mirabegron; oral

1.6

122.0

2897

17724

A02BA02

ATC

ranitidine; systemic

1.5

121.6

4978

34311

U04

ICPC

Incontinence urine

2.0

121.2

1323

6409

P01

ICPC

Feeling anxious/nervous/tense

1.5

121.1

4172

27776

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

121.0

3574

23015

XF402

NOMESCO Finland

ECG with work load test

1.7

121.0

2665

15997

RK320, ,

NOMESCO Finland

4.5

120.8

297

637

K78

ICPC

Atrial fibrillation/flutter

1.9

120.5

1649

8631

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

120.4

1795

9652

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.2

120.4

325

750

A08AX01

ATC

rimonabant; oral

21.2

120.1

A10BX02

ATC

repaglinide; oral

3.8

119.8

379

981

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

119.8

1421

7090

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.2

119.3

1012

4449

T92

ICPC

Gout

3.0

119.1

542

1763

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

118.4

2841

17419

C07BB07

ATC

bisoprolol and thiazides; systemic

2.2

118.0

1019

4513

C09DA07

ATC

telmisartan and diuretics; oral

2.1

117.9

1162

5420

D07AD01

ATC

clobetasol; topical

1.5

117.9

4831

33288

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

117.4

6116

44032

N03AX11

ATC

topiramate; oral

2.3

117.3

896

3768

M02AA10

ATC

ketoprofen; topical

1.5

117.3

4400

29790

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

117.2

114

N06AB05

ATC

paroxetine; oral

1.8

116.9

1884

10370

B02AA02

ATC

tranexamic acid; systemic

1.5

116.9

4688

32163

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

116.6

1169

5487

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

116.3

333

803

CK2S4, ,

SPAT

3.3

116.0

457

1365

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

115.7

1566

8165

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.6

115.6

696

2624

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.6

115.2

712

2718

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

19.6

114.8

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

114.7

2771

17013

SPAT1051

SPAT

Guidance regarding sleep disorders

2.9

114.6

561

1900

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

114.5

1684

9014

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

114.3

892

3786

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

114.3

3065

19293

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.5

113.7

3556

23171

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

113.6

2905

18081

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

113.5

969

4270

L13

ICPC

Hip symptom/complaint

1.5

113.4

4811

33344

R01AD12

ATC

fluticasone furoate; nasal

1.3

112.7

10382

81615

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

112.7

1559

8184

S20

ICPC

Corn/callosity

2.8

112.7

578

2008

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.4

112.5

825

3408

N05CF02

ATC

zolpidem; oral

1.4

111.9

5227

36870

G93.2

ICD-10 Finland

Benign intracranial hypertension

8.0

111.9

154

187

C09AA03

ATC

lisinopril; oral

2.1

111.1

1106

5178

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

111.0

3849

25625

Z2221

NOMESCO Finland

Medical doctor

1.3

110.6

8230

62680

Z01.2

ICD-10 Finland

Dental examination

1.3

110.6

14777

122014

D10

ICPC

Vomiting

1.7

110.6

2031

11605

M01AH02

ATC

rofecoxib; oral

1.6

110.6

3227

20702

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

110.5

3866

25784

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

110.4

3512

22960

J96.9

ICD-10 Finland

Respiratory failure, unspecified

5.1

110.3

235

447

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

109.8

5104

35963

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

109.7

8969

69253

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.3

109.6

818

3406

R01AD58

ATC

fluticasone, combinations; nasal

1.3

109.5

8064

61306

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

109.4

1749

9600

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.8

109.4

251

509

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.7

108.5

2010

11510

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

108.4

1879

10559

A08AA04

ATC

dexfenfluramine; oral

9.6

108.4

129

130

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

108.4

1801

9999

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

108.2

1341

6788

XQ800

NOMESCO Finland

Prick test

1.7

108.0

2393

14370

K85

ICPC

Elevated blood pressure

1.5

108.0

3914

26285

M15

ICD-10 Finland

Polyarthrosis

2.0

107.9

1280

6383

N06AA12

ATC

doxepin; systemic

1.9

107.8

1347

6838

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

107.4

1130

5399

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.9

107.3

525

1778

JAH01

NOMESCO Finland

Laparoscopy

1.9

107.2

1447

7535

R29

ICPC

Respiratory symptom/complaint other

1.7

107.1

1999

11469

J01DA06

ATC

[U] cefuroxime

1.5

107.1

4173

28428

212

Kela drug reimbursment

Gout

3.0

106.8

475

1525

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.4

106.8

732

2934

R99

ICPC

Respiratory disease other

2.7

106.6

585

2105

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

106.4

1226

6052

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

105.2

1830

10293

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

105.0

1689

9285

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

104.8

1032

4810

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

104.7

642

2442

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

104.5

526

1809

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

104.5

1387

7182

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.4

104.0

720

2899

A99

ICPC

Disease/condition unspecnature/site

1.6

103.9

2548

15685

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

103.9

923

4133

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.5

103.6

991

18783

ZXA10

NOMESCO Finland

Bilateral

1.4

103.5

4857

34244

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

103.5

657

2541

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

103.3

670

2617

A10AB04

ATC

insulin lispro; parenteral

2.1

103.1

970

4443

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

103.0

2009

11665

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

102.9

859

3751

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

5.9

102.7

188

311

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.8

102.5

1688

9343

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

102.4

1608

8775

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.8

102.4

234

473

S21

ICPC

Skin texture symptom/complaint

1.5

102.0

3904

26483

H3603, E113,

ICD-10 Finland

4.2

101.9

276

639

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

101.7

1119

5433

SPAT1059

SPAT

Spirometry at the office

1.9

101.3

1366

7109

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

101.0

1486

7950

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

101.0

701

2826

N01

ICPC

Headache

1.5

100.9

3509

23346

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

100.8

854

3752

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

100.7

1743

9787

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

100.5

2999

19314

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

100.3

1261

6412

WX892

NOMESCO Finland

Monitored bed care

1.7

100.2

1964

11415

D07AA02

ATC

hydrocortisone; topical

1.5

100.2

4188

28889

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.6

99.8

2207

13239

A10BB07

ATC

glipizide; oral

4.1

99.6

278

658

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

99.6

1355

7071

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

99.3

2022

11872

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.6

98.9

592

2225

A10BD15

ATC

metformin and dapagliflozin; oral

3.8

98.9

304

772

N30.0

ICD-10 Finland

Acute cystitis

1.4

98.8

4730

33444

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

98.6

976

4558

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

98.1

1103

5396

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

98.0

1037

4964

C08CA10

ATC

nilvadipine; oral

2.8

98.0

502

1743

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

97.7

2709

17154

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

97.5

382

1138

TK800

NOMESCO Finland

Hemodialysis

2.5

97.4

609

2338

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

97.2

527

1885

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.6

97.1

325

875

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

97.0

904

4124

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.2

97.0

882

3986

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.5

96.8

602

2305

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

96.5

1435

7700

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

96.4

738

3106

N04BC05

ATC

pramipexole; oral

1.7

96.2

1931

11292

EB1VA, ,

NOMESCO Finland

1.5

96.2

3765

25632

R4180, ,

SPAT

3.7

95.8

309

811

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

95.8

2095

12527

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.6

95.8

553

2042

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.9

95.7

1351

7132

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

95.7

680

2770

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

95.7

1517

8300

E000003, ,

ATC

1.9

95.4

1292

6731

R21

ICPC

Throat symptom/complaint

1.3

95.4

6975

52794

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

95.2

1110

5500

E87.5

ICD-10 Finland

Hyperkalaemia

3.0

94.7

438

1438

B01AC04

ATC

clopidogrel; oral

1.5

94.6

3493

23502

N05AE04

ATC

ziprasidone; systemic

3.9

94.6

280

692

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

94.5

3514

23679

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

94.5

944

4424

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

94.4

597

2305

RD160, ,

NOMESCO Finland

8.1

94.3

128

153

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

94.1

3497

23560

I11

ICD-10 Finland

Hypertensive heart disease

5.4

93.9

189

342

WX111

NOMESCO Finland

Local infiltration anesthesia

2.1

93.7

889

4084

D06AX01

ATC

fusidic acid; topical

1.5

93.0

2711

17354

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

92.9

1471

8044

SPAT1252

SPAT

Overall medication plan or its review

1.8

92.9

1618

9097

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

92.4

495

1760

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

92.1

695

2907

M76.6

ICD-10 Finland

Achilles tendinitis

1.8

92.0

1430

7777

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

91.8

559

2119

R52.2

ICD-10 Finland

Other chronic pain

2.0

91.8

1058

5221

AA43B, ,

NOMESCO Finland

26.2

91.8

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

91.5

760

3311

L12

ICPC

Hand/finger symptom/complaint

1.4

91.5

4672

33366

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

91.5

2664

17048

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

91.4

897

4174

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

91.2

978

4704

UJD02

NOMESCO Finland

Gastroscopy

1.9

91.1

1209

6256

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

90.7

3011

19818

SPAT1251

SPAT

Organisation of medication

2.1

90.6

890

4143

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.2

90.5

762

3338

O61.0

ICD-10 Finland

Failed medical induction of labour

3.1

90.5

386

1210

Z01.7

ICD-10 Finland

Laboratory examination

1.4

90.5

4170

29244

O80.8

ICD-10 Finland

Other single spontaneous delivery

1.8

90.3

1403

7628

C09BA03

ATC

lisinopril and diuretics; oral

2.5

90.3

569

2193

Z72.0

ICD-10 Finland

Tobacco use

2.2

90.3

806

3616

A29

ICPC

General symptom/complaint other

1.5

90.3

3263

21852

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

90.2

7157

54750

D01AE15

ATC

terbinafine; topical

1.7

90.1

1802

10524

N06AG02

ATC

moclobemide; oral

1.9

90.0

1192

6164

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

7.7

90.0

127

159

K86

ICPC

Hypertension uncomplicated

1.5

89.7

2922

19151

H36.01

ICD-10 Finland

Diabetic maculopathy

3.0

89.6

408

1328

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

89.6

1171

6030

I20.09

ICD-10 Finland

Unstable angina

1.9

89.6

1212

6312

E68

ICD-10 Finland

Sequelae of hyperalimentation

29.5

89.5

K80.8

ICD-10 Finland

Other cholelithiasis

2.6

89.4

527

1966

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

89.4

434

1464

A05

ICPC

Feeling ill

1.7

89.3

1843

10853

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

89.1

483

1728

C10AB02

ATC

bezafibrate; oral

3.5

89.0

310

857

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

89.0

1659

9505

Z50.1

ICD-10 Finland

Other physical therapy

1.8

88.9

1404

7671

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

88.9

1853

10939

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

88.8

1285

6836

NG2AA

NOMESCO Finland

Patella X-ray examination

2.2

88.7

755

3322

OAB42, ,

SPAT

1.5

88.6

2965

19540

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.4

88.4

647

2670

A10BD08

ATC

metformin and vildagliptin; systemic

3.9

88.4

260

640

R52.0

ICD-10 Finland

Acute pain

2.0

88.2

1010

4973

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

88.0

2806

18306

QDB10, ,

SPAT

2.7

87.9

475

1696

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.8

87.9

440

1509

X58

ICD-10 Finland

Exposure to other specified factors

1.4

87.9

4098

28788

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

87.7

1284

6855

D05AX52

ATC

calcipotriol, combinations; topical

1.7

87.4

1521

8548

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

87.4

1736

10119

S01

ICPC

Pain/tenderness of skin

1.8

87.3

1262

6711

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

87.2

509

1890

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

87.1

665

2796

SPAT1151

SPAT

Treatment of major wounds

3.2

86.9

347

1046

R06AX27

ATC

desloratadine; oral

1.3

86.8

9151

72685

J01FA01

ATC

erythromycin; systemic

1.4

86.8

4287

30417

Z2445

NOMESCO Finland

Psychologist

1.9

86.8

1217

6410

SGB30

NOMESCO Finland

Other complicated root filling

1.4

86.7

3672

25341

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

86.7

718

3124

A11CC03

ATC

alfacalcidol; systemic

2.4

86.7

631

2598

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

86.6

30795

283168

R03BA08

ATC

ciclesonide; inhalant

1.5

86.5

2524

16150

KMAK, ,

NOMESCO Finland

1.2

86.5

16612

141643

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

86.3

2908

19187

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

86.0

891

4231

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

86.0

1188

6228

L29

ICPC

Musculoskeletal sympt/complt other

1.6

85.9

2336

14713

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

4.0

85.8

243

582

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.5

85.7

642

13286

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

85.6

1037

5206

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

85.5

1227

6509

JDF21

NOMESCO Finland

Laparoscopic gastric banding

820.8

85.5

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.6

85.4

510

1915

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.9

85.3

400

1324

P74

ICPC

Anxiety disorder/anxiety state

1.8

85.3

1379

7586

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.0

85.1

387

1259

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.9

85.1

1119

5773

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

85.0

760

3411

R06AX22

ATC

ebastine; oral

1.4

85.0

5192

38147

N07BB01

ATC

disulfiram; oral

1.8

84.8

1236

6588

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

84.7

561

2214

E87.6

ICD-10 Finland

Hypokalaemia

2.1

84.7

865

4087

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

84.6

2030

12411

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

84.3

2006

12239

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.0

84.3

370

1180

D01AC03

ATC

econazole; topical

1.7

84.2

1505

8520

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

3.9

84.2

251

624

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

84.1

2153

13370

D07AB08

ATC

desonide; topical

1.5

83.8

3057

20493

WZC00, ,

SPAT

1.5

83.8

2878

19061

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

83.4

2006

12271

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

83.4

591

2405

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.3

83.4

323

956

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.7

83.2

1710

10054

N06AX22

ATC

agomelatine; oral

2.1

83.1

775

3536

S22

ICPC

Nail symptom/complaint

1.7

82.8

1695

9955

G04BD08

ATC

solifenacin; oral

1.7

82.5

1525

8714

D01

ICPC

Abdominal pain/cramps general

1.4

82.5

3483

24012

R04.0

ICD-10 Finland

Epistaxis

1.7

82.4

1730

10226

D09AB01

ATC

zinc bandage without supplements; topical

2.5

82.2

544

2146

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.6

82.2

483

1800

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

82.1

877

4211

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

81.9

1811

10849

N05BE01

ATC

buspirone; oral

2.1

81.7

854

4068

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

81.6

962

4783

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

81.5

2820

18699

D02AE01

ATC

carbamide; topical

1.6

81.4

1803

10804

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

81.3

690

3033

J01FA15

ATC

telithromycin; oral

1.5

81.3

2802

18566

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

80.8

1404

7885

RD130, ,

NOMESCO Finland

21.8

80.5

N05AH02

ATC

clozapine; systemic

2.4

80.5

568

2307

C08CA05

ATC

nifedipine; systemic

1.7

80.4

1438

8141

L02

ICPC

Back symptom/complaint

1.5

80.3

2939

19707

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

80.3

1136

5999

WZA00

NOMESCO Finland

Concise certificate

1.6

80.2

1903

11599

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

80.1

525

2061

C09DB01

ATC

valsartan and amlodipine; oral

2.0

80.0

856

4113

R05DA01

ATC

ethylmorphine; oral

1.6

80.0

2073

12904

WX110, ,

SPAT

1.6

80.0

1767

10582

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

79.7

997

5058

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

79.6

1234

6701

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

79.5

798

3745

SPAT1360

SPAT

Extensive global examination

1.6

79.5

1802

10860

M54.3

ICD-10 Finland

Sciatica

1.7

79.4

1627

9555

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

79.4

1885

11490

Z08

ICPC

Social welfare problem

2.7

79.3

424

1506

C07AB03

ATC

atenolol; systemic

1.8

79.1

1185

6370

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

2.6

79.0

461

1712

R07.3

ICD-10 Finland

Other chest pain

1.5

78.8

2666

17592

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

78.7

1555

9045

K92.1

ICD-10 Finland

Melaena

1.8

78.7

1204

6514

C10AA04

ATC

fluvastatin; oral

1.6

78.4

1768

10642

R05

ICD-10 Finland

Cough

1.3

78.3

5979

45359

UKC02

NOMESCO Finland

Cystoscopy

1.4

78.2

3575

24989

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

78.2

520

2056

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

78.0

771

3598

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.8

77.8

1313

7311

R03BB01

ATC

ipratropium bromide; inhalant

2.1

77.7

761

3539

-1, ,

NOMESCO Finland

1.3

77.6

10250

83437

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

77.5

724

3306

SPAT1202

SPAT

Intra-articular injection

2.1

77.5

760

3536

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

77.4

4486

32635

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

77.4

2785

18604

NHQ40

NOMESCO Finland

Amputation of toe

2.8

77.4

393

1359

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.1

77.2

337

1071

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.6

77.1

474

1806

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

76.9

2107

13282

E03

ICD-10 Finland

Other hypothyroidism

1.6

76.8

1673

9982

L01

ICPC

Neck symptom/complaint

1.4

76.7

4523

32992

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

76.6

1405

8009

F32.8

ICD-10 Finland

Other depressive episodes

2.4

76.4

532

2148

K03.66

ICD-10 Finland

Tooth plaque

1.6

76.2

1993

12430

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.5

76.0

188

406

R60.1

ICD-10 Finland

Generalized oedema

3.6

75.8

252

676

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

75.5

373

1271

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

75.4

734

3405

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

75.4

857

4208

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

75.3

934

4725

104

Kela drug reimbursment

Thyroid insufficiency

1.6

75.0

1807

11051

XA421

NOMESCO Finland

Nocturnal polygraphy

4.1

74.9

208

491

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.7

74.9

401

1426

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

74.7

492

1937

R73

ICD-10 Finland

Elevated blood glucose level

2.0

74.5

778

3705

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

74.4

525

2133

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.4

74.3

269

763

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.0

74.3

805

3886

SFD11

NOMESCO Finland

Gradual caries removal, at least two tooth surfaces

2.1

73.9

683

3106

N03AE01

ATC

clonazepam; systemic

1.7

73.8

1493

8738

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

73.8

804

3889

ZX120

NOMESCO Finland

Intravenous

1.5

73.6

2428

15930

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.9

73.5

887

4445

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

73.4

1327

7532

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

73.2

924

4701

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

73.2

955

4913

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

73.1

1046

5542

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

72.7

521

2131

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.2

72.6

610

2670

L03.3

ICD-10 Finland

Cellulitis of trunk

3.4

72.4

270

781

F31

ICD-10 Finland

Bipolar affective disorder

2.6

72.3

432

1623

S06

ICPC

Rash localized

1.7

72.3

1465

8577

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.2

72.2

658

2977

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.2

72.1

619

2734

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

72.1

947

4883

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.0

71.9

828

4083

G04BD07

ATC

tolterodine; oral

1.8

71.9

1054

5627

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

71.9

1021

5398

J01

ICD-10 Finland

Acute sinusitis

1.6

71.8

1683

10222

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

71.6

1071

5754

SPAT1325

SPAT

Vaccination

1.3

71.2

8676

69808

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

71.0

1347

7747

C07AB05

ATC

betaxolol; oral

2.3

71.0

555

2358

RD250, ,

NOMESCO Finland

+∞

70.9

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

70.8

794

3879

A97

ICPC

No disease

1.3

70.8

4869

36325

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.4

70.7

500

2033

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

70.7

801

3929

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

70.6

1686

10286

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

70.5

592

2592

M01AB55

ATC

diclofenac, combinations; oral

1.6

70.4

1539

9185

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.6

70.4

402

1477

C09AA04

ATC

perindopril; oral

1.8

70.3

1140

6272

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

70.3

1212

6789

N06AA04

ATC

clomipramine; systemic

2.4

70.2

481

1928

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.2

70.2

579

2516

N07BA03

ATC

varenicline; oral

1.7

70.1

1417

8288

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

70.1

931

4817

SPAT1285

SPAT

Provision of consultation response

1.7

70.0

1361

7879

K28

ICPC

Limited function/disability (K)

2.4

69.9

478

1915

S17

ICPC

Abrasion/scratch/blister

2.2

69.6

603

2673

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

69.4

451

1765

WZC30, ,

SPAT

1.7

69.2

1425

8375

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.5

69.2

461

1825

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.2

69.1

574

2502

R06AX13

ATC

loratadine; oral

1.3

69.1

4491

33214

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

69.0

829

4149

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

68.8

1597

9676

OAB74, ,

SPAT

3.3

68.8

262

768

-50

ICPC

Medication/prescr/renewal

1.8

68.8

1011

5402

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

68.7

1666

10200

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

68.5

790

3898

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

68.4

1057

5734

M54.1

ICD-10 Finland

Radiculopathy

1.8

68.3

1092

5984

N06AA06

ATC

trimipramine; systemic

2.1

68.2

646

2966

N06AA10

ATC

nortriptyline; systemic

2.2

68.2

616

2777

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

68.0

2716

18495

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

68.0

1286

7391

EMB10

NOMESCO Finland

Tonsillectomy

1.6

67.4

1805

11312

M77.4

ICD-10 Finland

Metatarsalgia

1.6

67.4

1703

10530

QBJ00

NOMESCO Finland

Liposuction in trunk

3.8

67.4

206

522

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

2.8

67.3

340

1173

L84

ICD-10 Finland

Corns and callosities

1.9

67.1

896

4644

C07AB08

ATC

celiprolol; oral

2.3

67.1

531

2268

IGY02, ,

SPAT

2.6

67.1

396

1480

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

67.0

1385

8147

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.9

67.0

321

1076

IHZ05, ,

SPAT

1.7

67.0

1149

6425

WVA30, ,

SPAT

1.7

66.9

1357

7944

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.7

66.7

1311

7610

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.5

66.7

233

646

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

66.7

2663

18129

H60

ICD-10 Finland

Otitis externa

1.6

66.6

1496

8988

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

66.5

1803

11331

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

66.4

5445

41612

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

66.3

1027

5574

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026782) Osmolality of Urine

7954

50372

1.68

318.96

3.3

2.7

557.58

537.88

mosm/kgh2o

9.46

6873

43165

(3002582) Erythrocytes [#/volume] in Urine

11302

78055

1.58

318.73

3.6

3.1

71.44

81.36

e6/l

0.33

8791

59110

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1590

5473

2.89

317.40

3.6

2.9

25.20

24.49

mmol/l

7.52

1560

5342

(3018095) Leukocytes [#/volume] in Urine

13100

93681

1.56

316.47

4.2

3.5

83.15

82.88

e6/l

0.01

9396

64187

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

30428

264238

1.82

308.23

17.2

11.2

85.85

85.57

ml/min/173m2

1.18

25958

216891

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4715

22775

2.15

307.65

2.3

0.22

g/l

0.00

4395

21314

(3019060) Gas panel - Arterial blood

3198

14456

2.25

307.65

5.2

4.9

—

(3018010) Neutrophils/100 leukocytes in Blood

17833

133554

1.58

307.65

6.5

5.8

58.60

56.62

107.95

16846

125971

(3013826) Glucose [Moles/volume] in Serum or Plasma

23181

153012

2.35

307.65

6.1

4.4

7.15

6.54

mmol/l

235.63

21750

141323

(3044640) Blood type and Crossmatch panel - Blood

12973

85546

1.73

307.65

2.5

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18194

131625

1.69

307.65

2.8

2.5

—

(3022096) Basophils/100 leukocytes in Blood

17004

125981

1.58

307.65

6.6

6.1

0.64

0.69

34.61

15940

117898

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

28235

221318

2.17

307.65

5.0

4.0

14.58

14.60

pmol/l

0.70

26292

203637

(3006315) Basophils [#/volume] in Blood

18908

139026

1.67

307.65

6.4

5.9

0.04

e9/l

8.15

16495

121548

(3019550) Sodium [Moles/volume] in Serum or Plasma

32855

284249

2.74

307.65

22.4

13.3

139.69

139.64

mmol/l

3.97

32382

277021

(3016244) Insulin [Units/volume] in Serum or Plasma

1215

1317

9.18

307.65

4.1

2.6

41.53

16.93

mu/l

44.55

1167

1219

(3012544) pH of Venous blood

4513

21767

2.15

307.65

4.7

4.0

7.37

7.38

0.76

149

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8432

39076

2.42

307.65

3.2

3.6

0.82

mmol/l

0.02

7977

36677

(3027801) Oxygen [Partial pressure] in Arterial blood

5144

25902

2.07

307.65

8.6

7.4

11.03

13.02

kpa

166.93

4922

24746

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7133

35765

2.16

307.65

2.9

2.4

2.48

2.36

g/l

47.80

6595

33152

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5411

24359

2.35

307.65

2.1

2.2

340.52

379.66

nmol/l

39.28

4911

22568

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2667

8542

3.18

307.65

3.8

3.7

24.88

24.74

mmol/l

1.68

2509

7912

(3026493) Urate [Moles/volume] in Serum or Plasma

13094

66888

2.41

307.65

2.9

2.4

3611.47

3653.30

umol/l

0.04

11546

59490

(3024354) Oxygen [Partial pressure] in Venous blood

3608

17097

2.15

307.65

4.0

3.3

4.78

4.65

kpa

3.29

3488

16556

(3022313) Gas panel - Capillary blood

3114

9584

3.34

307.65

3.6

3.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4392

21014

2.16

307.65

4.7

4.0

5.97

5.81

kpa

18.50

4268

20424

(3019309) Folate [Moles/volume] in Red Blood Cells

8449

41147

2.29

307.65

2.0

1.7

1206.02

1160.47

nmol/l

4.48

6842

31222

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14038

92768

1.76

307.65

4.3

3.1

50.92

61.09

ng/l

0.48

9222

56124

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9805

64869

1.63

307.65

2.4

2.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17279

100590

2.29

307.65

2.4

1.8

95.04

97.57

pmol/l

10.24

10302

52350

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

17878

110761

2.13

307.65

3.0

2.2

70.32

887.95

nmol/l

0.50

16579

101093

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

20266

135657

2.04

307.65

5.8

6.1

10.57

10.99

umol/l

5.05

19231

128475

(3020779) Urea [Moles/volume] in Serum or Plasma

4181

20368

2.11

307.65

9.2

7.7

10.91

8.86

mmol/l

52.82

3991

19488

(3021960) Folate [Moles/volume] in Serum or Plasma

10171

54540

2.12

307.65

1.7

1.5

20.27

20.40

nmol/l

0.36

9042

47094

(3002030) Lymphocytes/100 leukocytes in Blood

18067

135505

1.59

307.65

6.7

6.0

27.26

28.77

74.38

17087

127861

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

27471

207163

2.27

307.65

8.2

7.3

80.94

75.98

u/l

59.10

26266

195640

(3022948) Iron [Moles/volume] in Serum or Plasma

7622

39110

2.12

307.65

3.0

2.4

12.54

14.34

umol/l

3.18

7124

36612

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

31635

275345

2.07

307.65

5.4

4.0

1.27

1.49

mmol/l

307.65

29764

257849

(3013707) Erythrocyte sedimentation rate by Westergren method

25378

206098

1.67

307.65

4.7

3.9

15.60

10.65

mm/h

307.65

23704

192184

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

30900

265505

2.01

307.65

4.9

3.6

1.61

1.25

mmol/l

307.65

28861

247186

(3026008) Bacteria identified in Urine by Culture

12082

77715

1.76

307.65

3.3

2.8

—

(3019198) Lymphocytes [#/volume] in Blood

19291

143554

1.66

307.65

6.5

5.9

2.04

1.94

e9/l

11.59

17225

128387

(3024561) Albumin [Mass/volume] in Serum or Plasma

18733

107896

2.44

307.65

5.3

4.7

35.52

36.02

g/l

31.53

17714

100268

(3023368) Bacteria identified in Blood by Culture

11120

63651

2.00

307.65

4.8

4.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

20905

160062

1.64

307.65

9.2

9.0

4.59

3.99

e9/l

252.55

18359

140641

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6666

32991

2.17

307.65

3.0

2.5

20.80

23.62

53.62

5819

28312

(3023103) Potassium [Moles/volume] in Serum or Plasma

32888

285142

2.72

307.65

22.6

13.5

3.97

3.95

mmol/l

41.07

32374

277327

(3006504) Eosinophils/100 leukocytes in Blood

17611

130268

1.61

307.65

6.5

6.0

2.78

2.85

3.75

16584

122347

(3013115) Eosinophils [#/volume] in Blood

19449

143797

1.68

307.65

6.8

6.1

0.21

0.19

e9/l

34.14

17229

127483

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3983

13051

3.19

307.65

3.7

3.4

1.84

1.55

mmol/l

4.64

3000

9508

(3019069) Monocytes/100 leukocytes in Blood

17710

130990

1.61

307.65

6.9

6.3

8.03

8.43

60.85

16704

123280

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19020

124635

2.03

307.65

8.0

6.4

1.21

1.22

mmol/l

27.59

16479

106033

(3009343) pH of Capillary blood

4119

13515

3.20

307.65

3.7

3.4

7.41

7.42

5.93

470

1836

(1002224) Polysomnography panel

2876

11793

2.47

307.65

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9292

51934

1.99

307.65

2.0

1.6

29848339.66

38551810.79

pmol/l

0.74

7957

43669

(3013512) EKG study

10918

70190

1.73

307.65

4.6

3.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

17692

112473

2.04

307.65

16.2

11.9

1.22

1.20

inr

1.88

5069

33977

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1067

2642

3.99

307.65

1.2

27.06

30.84

nmol/l

0.25

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10267

60180

1.91

307.65

2.0

1.7

1.03

1.11

mg/l

1.91

8015

45233

(3037467) Urinalysis macro (dipstick) panel - Urine

24450

192253

1.74

307.65

5.0

4.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5146

25918

2.07

307.65

8.6

7.4

5.34

5.05

kpa

67.38

4936

24768

(3033658) Prothrombin time (PT) actual/Normal

10114

67206

1.63

307.65

4.4

3.8

93.06

92.62

0.93

9803

65461

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11561

62942

2.15

307.65

2.6

2.2

3.19

2.80

mg/l

51.29

10234

53825

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12991

83178

1.80

307.65

2.8

2.5

52.03

63.09

u/l

7.15

12043

76952

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

31776

277213

2.09

307.65

5.4

4.0

4.45

4.75

mmol/l

307.65

30054

260522

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

32203

281082

2.24

307.65

6.0

4.4

2.66

2.83

mmol/l

227.75

30367

262771

(3016502) Oxygen saturation in Arterial blood

4583

23147

2.05

307.65

9.0

7.8

94.67

96.05

38.34

4440

22251

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4156

13698

3.18

307.65

3.7

3.4

5.29

5.10

kpa

36.74

3957

12973

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17329

112698

1.95

307.65

7.4

5.7

1.21

mmol/l

21.80

16058

103218

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1624

5220

3.10

307.65

2.4

2.3

145.58

99.97

ug/min

2.69

999

3161

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1576

4640

3.38

307.65

1.9

2.3

1.05

0.80

nmol/l

25.25

1258

3961

(3009508) Creatinine [Moles/volume] in Urine

15721

75695

2.81

307.65

3.6

3.2

7.96

7.92

mmol/l

0.08

13378

64871

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12089

60700

2.40

307.65

3.4

2.8

1197.01

1148.04

ng/l

0.59

9992

51398

(3020682) Albumin/Creatinine [Ratio] in Urine

15540

70743

3.00

307.65

4.5

3.8

11.76

8.90

mg/mmol

8.29

10714

44148

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

31535

261804

2.56

307.65

6.2

4.6

2.11

2.07

mu/l

0.15

29716

243248

(3031040) Bacteria [#/volume] in Urine by Automated count

23124

182584

1.65

307.65

5.2

4.1

1304.62

1381.28

e6/l

0.08

373

2249

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15022

90370

2.05

307.65

3.3

3.2

32.55

32.62

u/l

0.04

14242

85926

(3007853) Bacteria identified in Skin by Aerobe culture

6221

30717

2.16

307.65

2.0

1.7

—

(3003396) Base excess in Arterial blood by calculation

5140

25909

2.07

307.65

8.6

7.4

1.40

0.93

mmol/l

11.92

4225

20555

(3002032) Base excess in Venous blood by calculation

4352

20973

2.14

307.65

4.7

4.0

2.04

1.78

mmol/l

4.09

3736

17920

(3001604) Monocytes [#/volume] in Blood

18860

138741

1.67

307.65

6.4

5.9

0.60

0.56

e9/l

74.31

16479

121432

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

24534

194560

1.71

307.65

4.0

2.9

56.23

43.21

u/l

80.55

23082

183663

(40760892) CBC W Ordered Manual Differential panel - Blood

17869

130977

1.64

307.65

6.8

6.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10362

69467

1.62

307.65

1.7

1.6

1.70

1.34

mmol/l

156.05

8751

59136

(3042936) Bacteria identified in Isolate by Culture

6622

35709

1.97

307.65

2.4

2.0

—

(3012516) Albumin [Mass/volume] in Urine

14794

67479

2.92

307.65

3.7

3.2

236.37

447.66

mg/l

10.13

10342

42260

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18794

128367

1.88

307.65

3.7

2.8

111.43

110.16

ug/l

0.16

17662

120291

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6225

34334

1.91

307.65

1.9

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

32385

284592

2.23

307.65

19.5

12.2

21.30

22.20

mg/l

6.02

29308

219772

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

31622

248263

3.26

307.65

8.8

4.9

42.65

38.65

mmol/mol

307.65

30123

231718

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6594

38338

1.81

307.65

2.0

1.8

—

(3018418) pH of Serum or Plasma

11193

74039

1.67

307.65

4.7

4.0

7.40

0.74

2129

14140

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

31691

267625

2.43

307.65

6.1

4.0

6.38

5.78

mmol/l

307.65

29681

247530

(3015377) Calcium [Moles/volume] in Serum or Plasma

12890

85922

1.71

307.65

3.0

3.4

2.34

2.35

mmol/l

14.17

11385

76487

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7524

29904

2.82

307.65

6.1

1.08

1.03

mmol/l

34.48

7154

27994

(3000991) Gas panel - Venous blood

3836

19700

1.99

306.98

10.2

8.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3506

17476

2.04

305.01

4.6

3.9

103.42

85.62

ng/l

17.32

3066

15332

(40768797) Stomach Pathology biopsy report

6053

36145

1.74

298.91

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

17854

137782

1.51

294.97

4.3

3.4

0.00

estimate

0.11

3932

27451

(3030467) Casts [#/volume] in Urine by Automated count

10386

71453

1.57

292.03

3.5

3.0

0.48

0.37

e6/l

4.47

8020

53566

(3009261) Glucose [Presence] in Urine by Test strip

17986

139237

1.50

291.05

4.3

3.4

0.01

0.00

estimate

0.41

3492

25860

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4049

21689

1.90

284.74

9.9

8.2

124.77

121.60

g/l

16.98

3972

21070

(3021601) Nitrite [Presence] in Urine by Test strip

17793

137921

1.49

282.66

5.7

4.5

0.00

estimate

0.49

3756

26436

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10836

75823

1.55

279.89

2.3

2.1

193.78

201.57

u/l

0.38

10188

71368

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1328

4445

2.96

278.40

3.6

3.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3855

20584

1.91

273.03

8.8

7.1

1.43

1.33

mmol/l

6.02

3754

20113

(3015736) pH of Urine

14831

111328

1.49

272.40

3.8

3.1

5.73

5.90

8.35

999

10078

(3044889) 12 lead EKG panel

22813

186930

1.50

269.07

4.2

3.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2325

10386

2.24

267.17

4.1

3.3

25.41

25.21

mmol/l

1.97

2266

10059

(4146454) Self-monitoring of blood glucose

828

2138

3.80

262.87

2.7

2.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2184

9569

2.28

262.79

5.0

3.7

50.15

48.83

1.58

2156

9471

(3021589) Normoblasts [#/volume] in Blood

16128

123696

1.48

262.48

11.2

8.9

0.00

e9/l

3.13

13270

101779

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

795

1999

3.90

262.07

1.4

1.3

1.72

1.35

nmol/l

12.49

734

1794

(3004119) Hemoglobin [Mass/volume] in Venous blood

2785

13513

2.07

258.81

4.1

3.3

130.55

129.65

g/l

1.19

2719

13201

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5952

36850

1.67

252.54

1.9

1.7

1.44

1.42

2.69

5216

32825

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2524

11930

2.12

251.14

10.8

9.7

24.67

24.23

mmol/l

8.13

2432

11593

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1196

4030

2.93

247.42

1.1

43.92

2991.35

iu/ml

0.67

271

941

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

282

268

10.22

247.03

1.0

1.1

71.23

91.13

ug/l

8.10

250

210

(3000850) Epithelial cells [#/volume] in Urine

8032

53835

1.57

245.08

2.9

2.5

7.58

6.00

e6/l

15.55

7213

48036

(36304419) Bacteria [Presence] in Urine

9979

70487

1.51

238.10

3.4

2.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1389

5174

2.65

237.44

3.3

3.1

8.27

8.52

kpa

6.14

1364

5047

(3021901) Oxygen saturation in Capillary blood

1158

3927

2.91

236.70

3.2

2.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5015

30145

1.71

236.26

2.7

7.75

8.02

umol/l

0.38

4227

26026

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

33307

302248

2.18

234.57

13.2

9.5

30.64

25.92

u/l

211.02

32547

292688

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4445

25913

1.75

233.64

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4453

26084

1.74

229.85

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

33130

300348

2.10

228.70

21.8

13.8

77.91

73.78

umol/l

51.79

33121

300233

(3037522) Nuclear Ab [Titer] in Serum

6207

40058

1.60

219.41

1.4

477.54

553.36

titre

2.54

1155

8154

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3290

17912

1.85

216.47

3.0

2.7

163.69

171.88

ng/l

0.61

2905

16259

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4995

30709

1.66

214.21

5.2

4.1

29.69

32.54

72.06

3938

21732

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2786

14444

1.93

212.98

10.9

9.3

1.47

1.37

4.47

2763

14358

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2782

14424

1.93

212.63

11.0

9.4

0.65

0.68

5.31

2761

14346

(3014007) Fractional oxyhemoglobin in Arterial blood

2786

14511

1.93

209.93

11.1

9.5

93.00

94.18

19.57

2774

14459

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2172

10439

2.07

205.49

3.6

2.9

1.44

1.29

6.29

2160

10385

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2135

10199

2.09

205.30

3.6

2.9

0.66

0.65

0.11

2125

10160

(3027945) Reticulocytes/100 erythrocytes in Blood

4272

25561

1.70

202.14

2.5

2.6

1.98

1.73

37.55

3756

22813

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2681

14160

1.89

193.00

8.5

7.1

25.07

24.48

mmol/l

10.93

2577

13443

(1616796) Gas panel - Central venous blood

1302

5234

2.45

189.37

4.8

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3165

17712

1.80

189.00

1.7

1.6

—

(40758558) Short blood count panel - Blood

9505

69080

1.45

186.68

6.7

6.9

—

(3019225) pH of Specimen

3976

23823

1.69

186.06

4.5

4.0

—

(4200892) Spirometry reversibility

3290

18708

1.77

185.90

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

511

1196

4.17

185.65

2.0

1.5

1.61

1.13

nmol/l

12.80

392

951

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2741

14770

1.86

185.03

8.4

7.1

25.17

24.70

mmol/l

7.22

2714

14651

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2252

11378

1.97

184.78

5.1

4.5

24.20

24.11

mmol/l

0.65

2198

11159

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1807

8523

2.10

179.13

2.2

2.0

1.90

2.09

ug/l

0.37

1605

7554

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2497

13304

1.87

174.28

1.8

1.6

—

(40761511) CBC panel - Blood by Automated count

32780

299188

1.83

173.74

18.5

11.4

—

(3034770) Mitochondria Ab [Titer] in Serum

1617

7392

2.16

173.70

1.2

1.3

996.00

938.15

titre

0.11

227

(3020891) Body temperature

1861

8992

2.05

172.79

5.7

4.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6404

43700

1.51

170.83

2.9

2.6

1.37

1.12

e6/l

2.32

3633

24448

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13675

107106

1.38

170.65

4.6

3.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2637

14386

1.83

170.53

1.6

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6527

44736

1.50

170.37

2.7

3.0

2.45

2.44

mmol/l

3.88

5580

39270

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6800

47163

1.48

166.95

4.1

3.4

332.67

519.30

ng/l

2.83

4909

33259

(3007164) IgA [Mass/volume] in Serum or Plasma

8034

57581

1.45

166.38

1.5

1.4

2.57

2.29

g/l

27.69

4901

35866

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1568

7201

2.15

166.35

3.3

0.34

0.35

u/ml

0.22

905

4067

(3020630) Protein [Mass/volume] in Serum or Plasma

3190

18569

1.72

164.90

2.0

2.6

66.83

66.68

g/l

0.54

2905

17045

(3007566) Smooth muscle Ab [Titer] in Serum

1613

7521

2.12

164.52

1.2

1.3

119.14

123.73

titre

0.08

151

703

(3000494) Fungus identified in Specimen by Culture

4850

31450

1.57

162.84

1.5

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6873

48029

1.47

161.74

1.3

9.24

11.28

u/ml

1.85

2646

19325

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5985

40734

1.50

160.45

3.0

2.8

5.06

2.98

e6/l

8.41

3237

21633

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7193

50877

1.46

158.54

1.3

31.46

33.18

iu/ml

0.23

2057

16477

(3029937) Albumin [Presence] in Urine by Test strip

9838

73666

1.40

157.79

4.7

3.7

0.01

0.00

estimate

0.79

3549

25648

(3018405) Lactate [Moles/volume] in Arterial blood

1638

7819

2.07

156.86

4.6

4.2

1.42

1.36

mmol/l

1.17

1606

7681

(3028026) IgM [Mass/volume] in Serum or Plasma

2773

15790

1.75

154.58

1.6

1.9

1.16

1.34

g/l

9.31

2526

14491

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9031

67014

1.40

151.45

1.3

1.52

1.62

u/ml

0.35

2447

18666

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1230

5338

2.27

149.86

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7589

54776

1.43

148.45

1.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

5461

37022

1.50

147.86

1.7

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1859

9476

1.94

147.75

1.4

1.3

8.67

10.42

u/l

8.78

1519

7783

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3152

18850

1.67

146.47

3.1

3.4

4.48

4.52

pmol/l

1.43

2763

16957

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4254

27480

1.56

143.76

3.5

4.4

235.86

239.90

u/l

1.06

4009

26113

(3005719) IgG [Mass/volume] in Serum or Plasma

3361

20674

1.63

139.44

2.3

2.7

10.61

10.50

g/l

0.81

3067

18983

(3008037) Lactate [Moles/volume] in Venous blood

1062

4471

2.33

138.87

3.9

2.8

1.64

1.54

mmol/l

2.76

1043

4369

(3023520) Reticulocytes [#/volume] in Blood

3097

18715

1.65

137.80

2.5

2.6

80.68

69.12

e9/l

43.38

2316

13993

(3010421) pH of Blood

1347

6287

2.11

136.64

5.6

3.5

7.41

7.42

4.86

1229

5750

(3013139) Helicobacter pylori Ag [Presence] in Stool

3097

18759

1.65

136.47

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3865

24730

1.57

135.64

2.6

2.5

51.86

44.15

u/l

0.24

3208

21303

(3027315) Oxygen [Partial pressure] in Blood

1210

5446

2.18

134.71

5.6

3.6

8.56

8.80

kpa

4.90

1183

5330

(3013290) Carbon dioxide [Partial pressure] in Blood

1203

5414

2.18

133.96

5.6

3.6

5.20

4.96

kpa

18.13

1176

5299

(3012501) Base excess in Blood by calculation

1202

5413

2.18

133.62

5.6

3.6

3.03

2.34

mmol/l

9.51

836

3562

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

973

4045

2.36

130.91

1.7

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

8502

63788

1.38

129.51

4.1

3.4

—

(3038515) Glucose [Moles/volume] in Venous blood

992

4195

2.32

128.31

4.1

2.9

7.88

7.41

mmol/l

4.67

976

4112

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2074

11438

1.80

128.18

2.0

1.6

5.17

3.62

mg/l

6.83

1943

7876

(3021387) Prolactin [Units/volume] in Serum or Plasma

2253

12779

1.75

126.38

1.7

1.6

306.04

311.56

mu/l

0.30

2014

11505

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1761

9309

1.87

124.81

5.9

4.9

1.79

1.69

2.38

1679

8678

(3004588) Protein electrophoresis panel - Serum or Plasma

2558

15075

1.69

124.78

1.8

2.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1175

5393

2.14

124.38

2.6

2.1

131.64

131.01

g/l

0.36

878

3895

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3851

25075

1.54

124.25

4.0

3.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5482

38355

1.45

124.05

2.2

30.20

29.61

8.98

5315

37224

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3208

20091

1.59

122.70

4.8

3.7

1.22

1.23

mmol/l

16.85

2850

17539

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1994

11016

1.79

122.37

1.4

1.6

11.67

13.13

u/ml

0.24

301

(3037121) Protein [Mass/volume] in Urine

1619

8387

1.90

122.11

3.0

3.2

0.38

0.32

g/l

1.82

764

3715

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1323

6408

2.03

121.28

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

1377

6769

2.00

121.11

5.0

4.5

3.90

3.86

mmol/l

2.55

1363

6714

(40767503) Oxygen content in Capillary blood by calculation

1092

4985

2.15

117.15

3.3

2.4

16.56

16.66

0.34

658

2488

(3007930) Methemoglobin/Hemoglobin.total in Blood

1711

9150

1.84

116.73

6.0

5.0

0.85

0.91

8.56

1634

8538

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

422

1198

3.43

116.19

1.7

1.6

2.90

9.79

nmol/l

0.81

346

994

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1871

10344

1.79

114.35

1.8

1.67

1.47

g/l

15.57

1604

8921

(3010015) Selenium [Moles/volume] in Serum or Plasma

147

165

8.63

113.86

2.2

1.7

1.32

1.33

umol/l

0.22

141

(3019150) Specific gravity of Urine by Refractometry

7884

59471

1.36

113.35

4.6

3.6

1.02

kg/l

0.12

1174

8964

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

524

1720

2.97

113.31

1.3

5.60

5.14

umol/l

1.66

485

1589

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2184

12771

1.69

109.20

12.5

9.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8105

61708

1.35

108.89

1.8

1.6

—

(3011985) Renin [Units/volume] in Plasma

833

3515

2.32

108.21

1.5

1.6

78.33

63.50

mu/l

1.18

740

3151

(3020876) Protein [Mass/time] in 24 hour Urine

652

2470

2.58

107.20

2.6

1.69

1.26

g/24h

3.26

351

1254

(3041096) Erythrocytes [Presence] in Urine by Automated

9800

76925

1.32

106.04

3.9

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

774

3207

2.36

104.84

3.1

3.0

0.81

nmol/l

0.11

610

2414

(3023183) Ammonium ion [Moles/volume] in Plasma

1061

5014

2.07

103.87

3.4

2.8

36.47

33.76

umol/l

2.84

982

4565

(1761482) Bacteria [#/volume] in Urine by Culture

1146

5573

2.02

103.73

4.4

3.7

—

(3017181) Myelocytes/100 leukocytes in Blood

3394

22325

1.52

103.23

4.3

4.1

0.85

0.96

1.57

1208

7147

(3021440) Promyelocytes/100 leukocytes in Blood

3255

21260

1.53

102.29

4.3

4.2

0.08

0.12

2.59

1072

6112

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1807

10221

1.74

101.77

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1598

8737

1.80

101.13

1.6

144.76

317.16

titre

2.84

345

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2967

19111

1.54

99.26

2.4

2.2

6.26

7.69

ug/l

2.80

2509

16870

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1849

10640

1.71

97.81

1.5

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

612

2366

2.52

96.47

2.8

2.2

—

(3035285) Chloride [Moles/volume] in Venous blood

620

2415

2.50

96.19

2.8

2.2

105.78

105.71

mmol/l

0.14

615

2394

(3041354) Potassium [Moles/volume] in Venous blood

620

2416

2.50

96.11

2.8

2.2

4.06

4.03

mmol/l

1.03

615

2395

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1429

7676

1.83

95.79

1.9

1.7

32.64

43.71

nmol/l

47.48

1381

7499

(3028717) Thiamine [Mass/volume] in Blood

147

203

7.01

95.61

1.3

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1093

5402

1.98

94.44

1.4

1.3

17.27

26.95

u/l

28.44

891

4470

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1648

9285

1.75

93.97

1.9

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

27743

250464

1.32

93.72

22.2

14.5

15.45

14.89

11.73

27464

246183

(3002179) Metamyelocytes/100 leukocytes in Blood

3104

20442

1.51

93.35

3.9

4.0

0.59

0.69

2.19

1059

6208

(3004775) Volume in Urine collected for unspecified duration

486

1706

2.77

92.94

2.3

738.26

659.99

2.63

331

1207

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2537

16020

1.57

92.46

2.5

2.2

5796.88

6163.66

u/l

0.25

972

6535

(3005322) IgE [Units/volume] in Serum or Plasma

2951

19273

1.52

92.28

1.3

266.74

228.23

u/ml

0.74

2757

17861

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

751

3257

2.25

91.41

1.3

1.4

453.95

374.05

pmol/l

0.25

671

2841

(3024666) Lithium [Moles/volume] in Serum or Plasma

484

1719

2.74

90.51

13.5

11.8

0.61

0.62

mmol/l

0.53

443

1581

(3025159) Blasts/100 leukocytes in Blood

3066

20328

1.50

89.04

4.4

4.2

0.09

0.34

3.40

891

5233

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2870

18825

1.51

87.72

2.8

2.1

8.67

12.32

nmol/l

121.85

2535

17049

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1302

7022

1.82

86.02

1.4

1.5

14.65

14.28

iu/ml

0.03

163

(46235355) HIV 1 and 2 tests - Meaningful Use set

8366

65854

1.30

84.66

2.0

1.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1220

6491

1.84

84.22

2.2

3.5

2.37

3.76

ratio

0.53

519

(3024928) Oxygen saturation in Venous blood

990

4919

1.97

84.19

4.1

3.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1463

8219

1.75

84.12

2.4

2.3

605.83

509.84

ug/l

0.23

1370

7622

(40761535) Cells panel - Urine sediment

3056

20481

1.48

83.89

3.9

3.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

980

4866

1.97

83.50

1.2

101.25

141.87

titre

0.38

107

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1246

6692

1.83

83.43

2.2

3.5

38.85

41.11

mg/l

0.34

952

5442

(3034860) Kappa light chains.free [Mass/volume] in Serum

1247

6701

1.82

83.35

2.2

3.5

54.46

57.74

mg/l

0.15

960

5446

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

565

2261

2.43

82.73

1.9

2.2

18.64

19.33

nmol/l

0.99

526

2157

(3001186) Copper [Moles/volume] in Serum or Plasma

241

590

3.96

82.58

1.8

1.2

17.56

16.83

umol/l

1.33

218

520

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

209

461

4.39

82.22

1.5

1.4

5.76

5.60

nmol/l

0.21

199

440

(3000492) Spirometry study

4029

28544

1.41

81.89

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

620

2602

2.32

81.57

11.0

7.5

8.24

7.12

mmol/l

2.81

513

2119

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

643

2741

2.29

81.56

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1900

11539

1.62

81.31

2.1

2.0

38.75

39.48

u/l

0.84

1685

10389

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1314

7227

1.78

81.27

2.0

1.7

—

(3000330) Specific gravity of Urine by Test strip

1979

12143

1.61

81.18

3.8

3.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1027

5245

1.92

80.51

2.1

1.8

151.92

193.54

pmol/l

29.32

951

5004

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4293

31002

1.38

77.56

7.9

6.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

682

3045

2.18

77.31

7.2

6.3

11.19

11.35

mg/l

0.39

626

2809

(3003694) ABO and Rh group [Type] in Blood

10518

85911

1.26

77.27

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1185

6415

1.81

77.25

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

756

3517

2.10

77.11

1.2

1.3

34.54

34.19

u/l

0.02

648

3083

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3224

22221

1.44

76.07

1.2

133.40

145.93

iu/ml

0.96

1163

8592

(3025941) Bacteria identified in Stool by Culture

2546

16818

1.50

74.71

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2056

13008

1.56

73.74

2.9

2.6

0.42

0.25

e6/l

3.36

2009

12591

(3035637) Corticotropin [Mass/volume] in Plasma

713

3342

2.08

71.29

1.6

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1299

7398

1.72

71.00

1.4

284.56

279.28

ug/g

0.39

721

4204

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

762

3685

2.02

69.97

1.2

1.3

0.19

0.25

nmol/l

0.41

230

(3048689) Calprotectin [Mass/mass] in Stool

4994

37484

1.33

69.55

2.3

2.4

139.57

124.32

ug/g

2.31

3971

29559

(3028271) Lactate [Moles/volume] in Capillary blood

774

3774

2.00

69.44

2.4

1.8

1.74

1.72

mmol/l

0.27

757

3681

(3000475) Leukocytes [#/volume] in Synovial fluid

1074

5869

1.79

67.80

1.7

1.6

14013.53

12722.87

e6/l

0.37

754

4306

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

951

5012

1.85

67.60

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

950

5010

1.85

67.38

1.4

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

758

3711

1.99

67.23

1.2

1.3

1.11

1.29

nmol/l

0.10

730

3571

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

700

3334

2.05

67.04

1.2

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

870

4487

1.89

66.16

1.9

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

739

3610

2.00

65.96

1.1

1.50

g/l

0.10

653

3294

(3016750) Collection duration of Urine

360

1294

2.70

65.90

2.1

2.2

496.72

500.68

min

0.30

259

998

(3028707) Methadone [Presence] in Urine by Screen method

1045

5720

1.79

65.59

2.4

2.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1218

6964

1.71

65.58

3.5

3.8

1.83

1.42

mg/l

36.74

1112

6477

(3052851) Hemolysis interference index of Serum or Plasma

1314

7703

1.67

64.42

3.1

2.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1423

8545

1.63

63.48

1.8

2.3

7.81

7.26

g/l

26.03

1289

7759

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1420

8524

1.63

63.43

1.8

2.3

4.02

3.65

g/l

18.26

1289

7744

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1421

8533

1.63

63.39

1.8

2.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1447

8730

1.62

63.33

1.5

1.8

0.26

0.23

g/l

44.19

1375

8285

(3017569) Oxygen content in Arterial blood

285

926

2.98

62.95

2.1

2.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

936

5046

1.81

61.81

2.2

3.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

753

3814

1.92

60.50

6.2

5.1

359.33

374.47

umol/l

2.04

668

3306

(21494755) Public health laboratory ask at order entry panel

2665

35136

0.71

60.16

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1471

9023

1.60

60.09

1.5

1.8

1.33

1.15

g/l

92.63

1405

8589

(3003129) Base excess in Capillary blood by calculation

194

511

3.68

60.05

1.6

1.7

0.81

0.57

mmol/l

0.35

186

476

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

421

1710

2.39

59.77

12.9

13.0

840.67

837.27

nmol/l

0.05

404

1657

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

436

1801

2.35

59.59

18.6

18.0

3145.92

1966.87

nmol/l

0.30

420

1729

(3017732) Neutrophils [#/volume] in Blood

2801

19626

1.41

59.57

3.0

2.6

5.16

4.72

e9/l

1.07

2252

16266

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

22814

204866

1.21

59.45

3.6

3.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

299

1032

2.81

59.20

2.0

2.1

184.87

82.56

ug/min

0.62

224

(3023323) Follitropin [Units/volume] in Serum or Plasma

2596

17994

1.42

58.67

1.4

1.3

20.48

27.80

iu/l

36.27

2169

15611

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1324

7965

1.63

58.58

1.8

2.3

10.08

10.12

g/l

0.14

1184

7139

(3009542) Hematocrit [Volume Fraction] of Blood

33901

319984

1.60

57.92

29.2

18.1

40.41

40.49

0.59

32449

302195

(3021788) Differential panel - Synovial fluid

846

4517

1.83

57.67

1.6

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

636

3111

1.99

56.59

2.3

1.7

89.27

90.28

4.17

624

3063

(3007461) Platelets [#/volume] in Blood

33919

320329

1.59

56.09

29.0

18.0

263.75

255.72

e9/l

95.56

33384

312795

(3022145) Colonoscopy Study observation

4084

30642

1.32

55.95

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1530

9636

1.56

55.70

2.0

1.7

—

(3035941) MCH [Entitic mass]

33925

320565

1.58

53.85

28.9

17.9

29.77

30.26

307.65

33644

316769

(3020717) Zinc [Moles/volume] in Serum or Plasma

350

1372

2.48

53.76

1.7

1.4

16.33

27.38

umol/l

14.32

338

1301

(3024731) MCV [Entitic volume]

33925

320610

1.58

53.25

28.9

17.9

90.05

90.69

119.54

33645

316798

(3026361) Erythrocytes [#/volume] in Blood

33926

320636

1.58

53.06

29.0

18.0

4.57

4.51

e12/l

118.03

33325

312336

(3010813) Leukocytes [#/volume] in Blood

33928

320667

1.58

52.95

29.0

18.0

7.43

6.63

e9/l

307.65

33311

312308

(3044941) Cell count panel - Synovial fluid

717

3743

1.87

52.54

1.5

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

458

2038

2.18

52.48

1.1

295.50

290.94

mg/l

0.63

387

1860

(3000963) Hemoglobin [Mass/volume] in Blood

33931

320752

1.57

52.29

29.2

18.1

135.16

135.64

g/l

7.83

33666

316982

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1215

7360

1.61

52.22

2.2

2.1

11.09

10.63

mg/l

1.20

1129

6896

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1003

5792

1.69

52.01

1.5

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

311

1174

2.57

51.72

2.1

2.2

154.33

141.65

umol/l

0.23

163

580

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1310

8107

1.58

51.46

1.8

2.3

3.02

2.90

g/l

4.14

1179

7324

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

593

2931

1.97

51.25

1.4

9.23

7.78

mmol/l

11.73

568

2838

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

595

2947

1.96

51.11

2.2

2.0

24.62

25.45

mg/l

0.13

188

780

(40768441) Liver Pathology biopsy report

425

1871

2.21

50.03

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2917

21159

1.36

49.85

3.0

2.5

65.04

69.86

ml/min/173m2

6.36

1367

7959

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

989

5765

1.67

49.50

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

801

4410

1.77

49.30

1.6

1.3

7.40

6.89

mmol/l

5.76

710

3961

(3019977) pH of Arterial blood

307

1184

2.51

48.86

2.9

2.5

7.41

7.43

1.53

121

390

(3036489) Thrombin time

1616

10611

1.49

48.30

1.9

2.1

21.11

21.35

0.74

1363

9140

(3023511) Choriogonadotropin [Units/volume] in Urine

1293

8101

1.56

48.11

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1190

7328

1.59

47.73

1.9

2.4

0.49

0.79

g/l

4.10

1033

6358

(40761536) Microorganisms panel - Urine sediment

3259

24206

1.33

47.42

4.7

3.6

—

(3012565) Volume of 24 hour Urine

317

1266

2.43

46.83

2.2

1915.44

2011.97

0.91

284

1146

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1338

8505

1.54

46.64

2.5

2.7

4.01

3.54

g/l

22.55

1271

8105

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

428

1945

2.14

46.55

1.1

1.3

—

31.25

u/ml

—

(3010838) Calcium [Moles/time] in 24 hour Urine

843

4796

1.71

46.20

2.1

1.9

5.26

5.24

mmol/24h

0.07

754

4303

(3020491) Glucose [Moles/volume] in Blood

436

2012

2.10

45.58

2.0

1.7

7.14

6.43

mmol/l

4.06

294

1533

(3011288) Drugs identified in Urine by Screen method

1424

9223

1.51

45.46

2.5

3.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1091

6671

1.60

45.09

1.8

2.2

36.85

38.26

g/l

11.54

959

5873

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1073

6541

1.60

44.91

1.8

2.2

0.00

0.03

g/l

4.83

981

6001

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

724

3982

1.77

44.74

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

455

2149

2.06

44.72

3.7

2.8

62.39

50.31

mg/l

0.48

344

1504

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

951

5639

1.64

44.55

1.5

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

820

4689

1.70

44.12

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

624

3315

1.83

43.31

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

625

3322

1.83

43.30

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

624

3320

1.83

43.10

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

867

5070

1.67

42.88

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

626

3361

1.81

41.98

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

637

3440

1.80

41.90

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

699

3881

1.75

41.83

2.7

3.3

1.24

1.58

2.17

614

3498

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3168

23832

1.31

41.82

1.4

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

990

6027

1.60

41.67

1.8

2.3

0.00

g/l

0.09

900

5503

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

583

3078

1.84

41.30

1.6

58.50

54.55

1.42

365

1959

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

469

2322

1.96

40.44

1.6

1.5

29.15

33.31

1.58

295

1445

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

728

4138

1.71

40.07

1.5

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

972

5948

1.59

40.05

1.8

2.3

0.00

g/l

-0.00

892

5492

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

618

3362

1.79

39.69

1.4

—

(40768804) Tissue Pathology biopsy report

13221

115570

1.17

39.26

2.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1372

9106

1.47

38.79

2.1

2.3

93.76

92.94

0.65

1306

8730

(3022621) pH of Urine by Test strip

2401

17552

1.34

38.62

3.3

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

709

4042

1.71

38.62

1.2

1.5

—

(4034850) Laboratory test

1304

8577

1.48

38.58

10.8

8.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1702

11846

1.41

37.15

1.3

0.45

0.96

u/ml

2.69

174

1006

(3044242) Glucose [Moles/volume] in Arterial blood

248

998

2.41

36.17

2.2

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

780

4644

1.63

36.00

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1262

8362

1.47

35.97

2.4

2.6

194.13

180.89

6.11

1197

7917

(3037756) Immunofixation for Serum or Plasma

759

4493

1.64

35.84

1.3

1.8

—

(36660697) Celiac disease serology panel - Serum

3125

23993

1.28

34.98

1.2

—

(3001556) Androgen free Index in Serum or Plasma

116

313

3.58

34.87

1.3

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

169

574

2.85

34.72

1.2

318.18

341.76

pmol/l

0.23

118

435

(3047181) Lactate [Moles/volume] in Blood

1176

7750

1.48

34.45

7.5

5.5

1.39

1.27

mmol/l

4.96

1064

6848

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

631

3601

1.70

34.29

1.4

—

(3036603) Volume of Urine

356

1702

2.03

33.98

1.5

1.6

2046.91

1992.30

0.45

345

1663

(3044927) Protein electrophoresis panel - Urine

405

2026

1.94

33.97

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

233

947

2.38

33.29

3.1

2.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1517

10568

1.40

32.90

2.0

2.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1463

10129

1.41

32.89

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

716

4271

1.63

32.83

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

871

5449

1.56

32.65

4.6

3.1

24.30

26.11

mg/l

0.72

577

3332

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

691

4091

1.64

32.65

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4930

40109

1.22

32.62

2.1

2.0

—

(40768443) Skin Pathology biopsy report

1647

11665

1.38

32.35

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

153

512

2.89

32.33

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

754

4572

1.60

32.33

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

228

931

2.37

32.25

2.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

269

1180

2.21

32.16

1.5

1.4

434.68

695.43

mu/l

1.76

257

1124

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

551

3084

1.73

32.15

1.4

—

(3022689) Creatine [Moles/volume] in Urine

186

692

2.60

32.09

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

617

3565

1.68

32.04

2.7

2.6

364.68

534.55

u/ml

0.18

611

3514

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

503

2747

1.78

31.98

1.2

57.96

63.00

u/l

1.18

459

2460

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1333

9140

1.42

31.65

1.6

1.8

—

(3004451) EKG impression Narrative

240

1016

2.29

31.27

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1683

12033

1.37

31.16

1.1

1.47

11.75

u/ml

2.02

179

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1789

12924

1.35

30.99

2.4

2.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

680

4065

1.63

30.93

1.5

1.7

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

271

1212

2.17

30.90

1.5

1.4

72.74

72.87

0.05

259

1156

(3014765) Yersinia sp identified in Stool by Organism specific culture

1227

8331

1.44

30.76

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

679

4064

1.62

30.74

1.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

568

3254

1.69

30.48

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1215

8253

1.44

30.39

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1225

8349

1.43

30.08

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

398

2066

1.87

29.90

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

398

2066

1.87

29.90

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

398

2066

1.87

29.90

1.4

1.7

—

(3002256) Pathology report gross observation

4434

36000

1.22

29.71

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5394

44611

1.20

29.71

2.2

2.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

265

1199

2.14

29.37

1.7

1.8

1.89

1.98

umol/l

1.20

251

1121

(3010144) Erythrocytes [#/volume] in Synovial fluid

426

2272

1.82

29.36

1.5

1.4

105126.89

98521.37

e6/l

0.08

312

1556

(3023419) Bacteria identified in Sputum by Culture

593

3478

1.66

29.12

2.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

273

1256

2.11

28.98

1.2

179.41

152.79

mmol/24h

4.92

273

1256

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

316

1538

1.99

28.78

1.4

1.5

19.91

24.39

u/ml

0.96

288

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

419

2240

1.81

28.66

1.2

145.24

180.68

titre

0.46

385

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

744

4641

1.56

28.30

1.3

1.2

4.24

3.85

u/ml

0.33

311

2062

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1419

10025

1.38

28.29

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

416

2235

1.80

28.01

1.2

210.91

158.31

titre

0.18

(3008898) HLA-B27 [Presence]

1563

11244

1.36

27.80

1.1

—

(3006270) Folate [Moles/volume] in Blood

386

2035

1.84

27.65

1.2

1.1

384.40

377.87

nmol/l

0.24

303

1810

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2563

30668

0.79

27.38

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

759

4800

1.54

27.16

1.3

1.2

3.70

3.44

u/ml

0.13

233

1650

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

562

3314

1.65

27.06

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

188

764

2.38

26.98

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

144

516

2.70

26.86

1.3

99.07

78.58

mu/l

0.40

106

395

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

301

1478

1.97

26.78

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

462

2602

1.72

26.46

2.7

3.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

725

4573

1.54

26.27

1.4

1.6

0.67

0.74

g/l

1.09

552

3475

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

296

1456

1.97

26.21

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

739

4707

1.53

25.61

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1664

20849

0.76

25.57

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

706

4455

1.54

25.54

1.1

125.43

117.58

7.91

630

4035

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1117

7727

1.41

25.25

2.5

2.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

241

1121

2.08

24.94

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

241

1122

2.08

24.88

1.3

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

920

6161

1.45

24.88

1.5

1.4

12.81

20.36

u/ml

2.13

117

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1004

6837

1.43

24.81

1.2

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

337

1764

1.85

24.76

1.6

1.4

5.66

5.50

mmol/l

1.70

317

1676

(3000012) Reticulocyte production index

512

3018

1.65

24.74

2.1

—

(3045414) Leukocytes [Presence] in Urine

1689

12508

1.32

24.65

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

260

1250

2.01

24.60

2.2

2.1

22.84

27.56

umol/l

0.26

112

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

922

6192

1.45

24.56

1.5

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1255

8927

1.37

24.00

1.7

1.6

1.68

6.20

iu/ml

0.89

267

1787

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

236

1111

2.06

23.68

1.7

1.8

28.38

29.22

umol/l

0.60

231

1065

(3004716) Salmonella sp identified in Stool by Organism specific culture

2116

16238

1.27

23.50

1.4

—

(3039000) Anion gap in Blood

806

5328

1.47

23.34

8.8

6.6

11.37

11.17

mmol/l

0.96

738

4785

(3018572) Chloride [Moles/volume] in Blood

806

5329

1.47

23.32

8.8

6.6

105.17

105.27

mmol/l

0.27

738

4786

(3018851) Theophylline [Moles/volume] in Serum or Plasma

169

3.89

23.15

1.7

1.9

44.84

45.78

umol/l

0.09

169

(43055514) Macroprolactin [Presence] in Serum or Plasma

202

904

2.16

23.15

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2109

16210

1.27

23.12

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

134

505

2.57

22.69

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

1696

12714

1.30

22.62

2.0

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

1813

13713

1.29

22.59

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

335

1804

1.80

22.50

1.6

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

402

2284

1.71

22.39

1.5

2.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

276

1401

1.91

22.37

1.1

6.76

10.40

u/ml

1.07

256

(3034274) Bile acid [Moles/volume] in Serum --fasting

783

5202

1.46

22.12

2.1

2.2

5.45

6.39

umol/l

1.37

570

3785

(3017315) Amylase [Enzymatic activity/volume] in Urine

280

1437

1.89

21.95

1.4

1.2

276.84

324.12

u/l

0.40

264

1338

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

407

2336

1.69

21.85

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

210

977

2.08

21.80

1.3

1.4

13.22

14.78

pmol/l

3.89

175

825

(3027008) Opiates [Presence] in Urine

1814

13807

1.28

21.51

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2076

16085

1.26

21.25

2.7

3.1

37.81

48.98

u/ml

2.02

1991

15553

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

102

346

2.85

21.22

14.4

9.5

5.49

5.32

mmol/l

0.23

102

346

(4062490) Immunoglobulin typing, IgG

485

2934

1.60

21.18

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

844

5735

1.43

21.16

1.5

108.46

112.23

u/ml

0.56

203

1282

(3028300) Cannabinoids [Presence] in Urine

1815

13844

1.28

21.16

2.0

2.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

902

6212

1.41

20.97

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

196

903

2.10

20.90

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

482

2928

1.60

20.70

1.4

2.84

2.99

g/l

1.03

341

2066

(1761868) Lipid panel - Serum or Plasma

12041

107728

1.12

20.62

3.4

2.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

451

2699

1.62

20.60

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

482

2933

1.59

20.55

1.4

6.34

6.82

g/l

2.43

337

2069

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

388

2236

1.68

20.55

3.2

2.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

261

1340

1.89

20.48

1.2

1.3

73.33

75.82

titre

0.04

110

(3024139) IgG subclass 3 [Mass/volume] in Serum

481

2929

1.59

20.45

1.4

0.40

g/l

0.04

340

2072

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1051

7460

1.37

20.41

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

356

2010

1.72

20.34

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1454

10845

1.31

20.15

1.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

164

715

2.22

20.13

2.3

1.8

6963.30

11681.90

e6/l

0.65

381

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

265

1377

1.86

20.05

1.2

1.3

595.88

403.00

titre

0.26

(3050129) First trimester maternal screen panel - Serum or Plasma

1878

14482

1.26

20.00

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

850

5843

1.41

19.99

1.3

278.02

264.78

u/ml

0.68

520

3855

(3026692) Albumin [Mass/volume] in Peritoneal fluid

137

556

2.38

19.88

1.5

1.4

13.26

13.34

g/l

0.03

111

411

(3051101) Glucose [Moles/volume] in Cord blood

338

2.80

19.80

6.1

5.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

286

1528

1.81

19.80

1.2

1.3

80.07

88.77

u/l

1.09

254

1334

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

204

977

2.02

19.64

1.9

2.5

0.66

1.21

ug/l

6.25

186

930

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

124

488

2.46

19.26

1.3

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

307

1690

1.76

19.23

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

178

818

2.10

19.16

2.3

1.9

3297.58

3344.06

e6/l

0.01

120

557

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

370

2148

1.67

19.10

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

278

1492

1.80

18.98

1.2

1.3

21.00

22.89

u/l

0.36

239

1287

(3002331) Protein [Mass/volume] in Peritoneal fluid

122

481

2.45

18.89

1.5

1.4

26.71

28.68

g/l

0.25

369

(3032057) Clostridioides difficile [Presence] in Stool

121

477

2.45

18.74

2.0

1.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

236

1209

1.89

18.70

1.5

5.15

3.83

0.58

280

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

677

2.20

18.57

3.7

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

154

677

2.20

18.57

3.7

2.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

115

445

2.50

18.54

3.6

2.1

7.81

7.38

mmol/l

0.44

266

(3017354) Segmented neutrophils/100 leukocytes in Blood

403

2411

1.62

18.49

2.7

3.3

58.70

56.43

1.46

339

2067

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

512

3242

1.53

18.38

1.8

1.6

8.51

7.52

mmol/l

18.02

479

3127

(3027944) Amphetamines [Presence] in Urine

1759

13595

1.26

18.38

1.9

2.0

—

(3049717) Cytology report of Urine Cyto stain

1134

8278

1.33

18.35

2.3

2.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

512

3245

1.53

18.31

1.2

1.1

98.33

94.59

2.37

481

3040

(3033799) Differential panel - Peritoneal fluid

158

708

2.16

18.18

2.4

1.9

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

239

3.07

18.14

1.6

1.5

107.78

111.99

ug/l

0.12

200

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

305

1708

1.73

18.02

1.5

1.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

5.94

17.98

4.9

5.6

0.23

0.25

mmol/l

0.14

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

348

2022

1.67

17.94

1.1

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1057

7673

1.34

17.78

1.3

4.90

9.27

u/ml

3.03

134

1226

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1137

8348

1.32

17.68

1.3

29.82

37.09

u/ml

0.31

523

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1006

7255

1.35

17.68

1.4

126.86

118.76

pmol/l

0.25

971

7082

(3039443) Prostate specific Ag panel - Serum or Plasma

289

4699

0.59

17.66

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

253

2.98

17.66

8.8

7.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

173

812

2.06

17.66

6.9

6.2

25.76

24.91

mmol/l

1.47

157

743

(3000093) Morphology [Interpretation] in Blood Narrative

382

2283

1.62

17.63

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

871

6144

1.38

17.63

1.2

1.3

4.71

5.39

u/ml

0.12

476

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

452

2817

1.55

17.47

1.5

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

339

1972

1.66

17.42

3.2

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

539

3495

1.50

17.32

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

858

6057

1.38

17.29

1.2

12.95

14.88

u/ml

0.08

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

451

2818

1.55

17.24

1.5

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

303

1716

1.71

17.22

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4620

39281

1.15

17.21

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

400

2437

1.59

17.07

1.5

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

357

2130

1.62

16.63

1.4

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

882

6299

1.36

16.55

1.2

1.3

4.03

3.67

mmol/l

14.59

818

5920

(3019420) Tryptase [Mass/volume] in Serum or Plasma

287

1620

1.71

16.53

1.3

1.5

6.79

8.10

ug/l

1.29

259

1462

(3042631) Mycobacterium sp identified in Specimen

478

3054

1.52

16.52

2.3

2.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

157

730

2.08

16.47

1.5

1.4

54.51

52.08

0.33

137

624

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1097

8100

1.32

16.41

1.5

1.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

239

1286

1.80

16.27

1.2

1.1

3.71

3.64

iu/ml

0.04

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1031

7557

1.33

16.25

1.3

6.75

6.30

u/ml

0.07

798

(40762365) Oxygen content in Arterial blood by calculation

358

2.56

16.24

3.3

2.8

14.90

14.91

ml/dl

0.01

333

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

317

1847

1.66

16.23

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

318

1856

1.66

16.17

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

427

2681

1.54

16.01

1.4

1.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

507

3303

1.49

15.96

1.2

1.1

1.10

2.20

iu/ml

—

(3024263) Appearance of Synovial fluid

234

1266

1.79

15.66

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

331

1973

1.62

15.52

1.1

1.06

ratio

0.07

106

725

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

232

1266

1.77

15.10

1.4

2.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

233

1284

1.76

14.68

1.9

2.3

22.26

170.19

ug/l

1.82

222

1223

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

298

1762

1.64

14.47

2.1

99.97

98.39

0.36

275

1628

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

230

1270

1.75

14.40

1.4

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

282

1648

1.66

14.34

1.5

1.6

6.09

7.17

u/l

0.83

221

1326

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

970

7184

1.31

14.25

1.3

525.54

513.33

mg/l

0.14

922

6852

(3051611) Lipemic interference index of Serum or Plasma

408

2608

1.51

14.15

3.4

3.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

241

1356

1.72

14.13

1.1

21.52

24.11

u/l

0.38

222

1228

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

249

1419

1.70

13.95

1.6

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

240

1357

1.71

13.84

1.1

80.86

83.27

u/l

0.25

224

1229

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

193

1028

1.82

13.68

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1012

7582

1.30

13.66

1.9

11.93

20.15

iu/l

0.32

360

2902

(44813793) Dust mix specific IgE antibody measurement

353

2211

1.55

13.48

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

347

2169

1.55

13.37

1.2

1.3

0.78

1.75

u/ml

2.22

187

1188

(3051593) INR in Capillary blood by Coagulation assay

179

939

1.84

13.34

13.0

8.8

—

(3038026) Centromere Ab [Units/volume] in Serum

356

2246

1.53

13.16

1.2

48.43

47.05

u/ml

—

104

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1148

8786

1.27

13.10

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

777

5661

1.33

12.87

5.1

6.0

7141.92

1260.23

iu/ml

0.44

846

(3003327) Ova and parasites identified in Stool by Light microscopy

1341

10473

1.24

12.85

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

314

1940

1.57

12.77

2.1

1.9

2.23

2.13

u/field

0.11

139

904

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

474

3192

1.44

12.69

2.4

2.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

362

2312

1.52

12.67

1.6

1.5

1.27

1.41

promille

1.11

277

1767

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

200

1103

1.75

12.65

1.1

1.2

0.32

0.30

g/l

2.82

160

869

(3020961) Endomysium IgA Ab [Titer] in Serum

1841

14886

1.20

12.54

1.1

214.10

200.97

titre

0.05

374

(3003181) Sodium [Moles/volume] in Urine

553

3839

1.40

12.48

1.3

1.4

63.19

64.03

mmol/l

0.16

403

3042

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

242

1412

1.66

12.46

1.1

100.10

96.20

1.11

178

1136

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

345

2191

1.52

12.41

1.2

77.00

66.21

u/ml

0.22

106

(3051651) Icteric interference index of Serum or Plasma

256

1519

1.63

12.35

3.7

—

(3044007) Cell count panel - Peritoneal fluid

134

656

1.97

12.34

2.4

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

345

2197

1.52

12.26

1.2

68.71

42.29

u/ml

0.80

172

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

101

446

2.19

12.23

2.1

2.7

106.26

32.07

mg/l

1.37

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

187

1023

1.77

12.19

1.1

1.2

110.57

111.17

0.13

164

919

(3036180) Methadone [Presence] in Urine

253

1502

1.63

12.18

1.9

2.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

607

4304

1.37

12.06

2.3

3.0

502.73

7431.20

u/ml

1.40

239

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

110

508

2.09

11.90

3.0

2.4

—

(3042733) HLA Ab [Presence] in Serum

182

995

1.77

11.90

5.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

397

2.24

11.80

4.1

4.8

65.13

39.96

ug/min

1.94

300

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

197

1105

1.72

11.78

3.0

3.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

270

1643

1.59

11.77

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

165

2.98

11.74

2.0

1.3

356.61

326.28

umol/24h

0.42

165

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1445

11487

1.22

11.74

1.4

1.3

190.64

227.34

miu/ml

3.76

604

5578

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

137

689

1.92

11.70

1.5

1.2

80.19

134.54

nmol/l

5.05

518

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

265

1609

1.59

11.66

1.0

1.1

2.37

5.92

nmol/l

1.41

307

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

330

2107

1.52

11.61

1.2

6.58

10.81

u/ml

0.53

161

(3023420) DNA double strand Ab [Units/volume] in Serum

476

3263

1.41

11.60

1.5

1.6

32.88

34.61

iu/ml

0.11

163

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

113

533

2.05

11.57

1.2

15.65

58.47

mg/l

1.08

393

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2605

21845

1.16

11.53

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

220

2.68

11.52

1.3

669.01

232.76

mg/24h

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

221

2.67

11.42

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.88

11.40

2.1

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1050

8091

1.26

11.37

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

190

1067

1.72

11.34

3.0

2.8

—

(3044290) Cell count panel - Cerebral spinal fluid

797

5958

1.30

11.03

1.3

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

216

1271

1.64

10.84

1.6

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

285

2.41

10.79

3.0

2.5

1.18

1.17

mmol/l

0.01

200

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

171

946

1.75

10.79

2.6

2.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

842

6363

1.28

10.73

1.4

1.5

1034.89

2390.04

e6/l

1.05

685

5158

(3022493) Free Hemoglobin [Mass/volume] in Plasma

188

1071

1.70

10.68

6.2

5.1

2083.27

3093.91

mg/l

0.28

133

792

(3026389) Candida sp identified in Specimen by Organism specific culture

601

4340

1.34

10.66

1.4

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

422

2.13

10.59

5.7

65.58

69.86

0.75

330

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

840

6358

1.28

10.58

1.3

1.4

62.63

22.84

e6/l

1.04

650

4902

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

313

2022

1.50

10.47

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

311

2007

1.50

10.46

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

917

7045

1.26

10.23

2.6

2.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2406

20238

1.16

10.22

2.3

21.91

22.67

au/ml

0.12

127

1763

(40768800) Prostate Pathology biopsy report

300

4259

0.68

10.17

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2218

18555

1.16

10.14

1.3

36.17

50.19

au/ml

1.88

935

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

215

1288

1.61

10.08

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

593

4329

1.33

9.81

1.2

—

(40768446) Kidney Pathology biopsy report

189

1107

1.65

9.72

1.6

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

176

1013

1.68

9.68

1.5

2.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

174

999

1.68

9.66

3.5

4.0

—

(3006462) Nitrate [Presence] in Urine

216

1311

1.59

9.62

3.5

2.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

872

6719

1.26

9.52

1.1

1.35

2.19

u/ml

3.27

482

3307

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1482

12062

1.19

9.46

1.4

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

267

2.35

9.44

1.1

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

677

5065

1.29

9.39

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

611

4511

1.31

9.36

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

131

701

1.81

9.32

1.7

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

400

2.08

9.25

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

172

997

1.67

9.23

1.5

2.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

804

9702

0.79

9.21

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

327

2189

1.45

9.20

3.3

3.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

241

2.40

9.17

2.0

2.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

752

5728

1.27

9.07

1.1

0.72

1.17

u/ml

1.65

330

2386

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1045

12237

0.82

9.03

1.5

1.4

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

191

2.58

9.03

2.9

2.2

69.58

56.97

1.57

114

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

385

2.08

9.00

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

171

997

1.66

8.99

1.5

2.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

786

6032

1.26

8.91

1.1

3.77

5.44

u/ml

3.48

424

3057

(3043238) Trisomy 21 risk [Likelihood] in Fetus

828

9916

0.80

8.88

1.6

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

912

7127

1.24

8.82

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1335

10836

1.20

8.81

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

823

6365

1.25

8.74

1.2

34.56

43.29

u/ml

0.76

631

(3005033) Fetal Nuchal fold Thickness US

808

9678

0.80

8.69

1.5

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

439

1.98

8.54

1.1

1.0

0.29

0.35

u/ml

0.09

263

(3012494) Peanut IgE Ab [Units/volume] in Serum

159

923

1.66

8.53

1.1

2.42

6.42

u/ml

0.53

527

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

138

771

1.73

8.52

1.6

10.77

8.71

ug/l

4.57

138

771

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

294

1962

1.45

8.45

1.1

7.55

8.53

iu/ml

0.39

514

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

367

2550

1.39

8.42

1.4

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

1542

0.52

8.42

1.5

—

(40768793) Breast Pathology biopsy report

541

6765

0.77

8.34

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

239

1541

1.50

8.19

1.2

28.93

10.47

u/ml

0.30

167

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

338

2331

1.40

8.12

1.8

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

124

684

1.75

8.04

1.3

1.2

36.97

40.21

g/l

1.63

360

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

391

2.00

7.94

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

143

2.70

7.81

1.6

1.7

0.64

0.71

0.11

106

(3016018) Differential panel - Cerebral spinal fluid

431

3113

1.34

7.78

1.3

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

103

543

1.83

7.78

1.1

0.89

0.77

umol/24h

0.20

276

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

746

5795

1.25

7.68

1.5

1.4

0.40

0.43

nmol/l

0.44

600

4565

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

150

2.64

7.66

2.9

2.3

13.67

16.88

0.35

(3008295) Osmolality of Serum or Plasma

346

2423

1.38

7.63

1.5

284.63

279.90

mosm/kgh2o

3.19

259

1909

(3001729) Color of Synovial fluid

173

2.51

7.62

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

151

2.62

7.57

1.2

134.65

104.82

ug/l

0.65

(3003434) Protein [Mass/volume] in Pleural fluid

373

2650

1.36

7.52

1.5

1.4

33.59

33.85

g/l

0.15

345

2400

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

226

1470

1.49

7.47

1.1

—

(3002619) Bacteria identified in Specimen by Culture

101

537

1.82

7.45

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

412

2978

1.34

7.43

1.2

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

262

1759

1.44

7.37

2.7

3.3

100.93

130.15

nmol/l

1.39

257

1725

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5414

56076

0.92

7.34

3.9

4.0

22.50

21.74

2.45

2147

26010

(3024932) HLA-DR beta [Type]

160

971

1.59

7.27

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

593

4521

1.27

7.20

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

283

2.12

7.11

1.1

1.3

—

0.96

mmol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1086

8832

1.19

7.10

1.1

4.07

5.42

u/ml

0.73

126

1277

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

134

2.67

7.08

1.0

0.29

0.08

u/ml

0.69

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

397

1.92

6.96

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

504

3783

1.29

6.95

1.3

1.2

38.81

53.00

u/ml

0.66

262

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

362

4654

0.75

6.93

3.0

3.6

26.51

37.25

u/ml

1.33

344

4492

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

177

1113

1.54

6.91

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

217

1425

1.47

6.88

1.7

2.40

u/field

0.00

150

1034

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

295

2.06

6.78

2.0

—

(3024471) HLA-A [Type]

161

999

1.56

6.69

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

216

1426

1.46

6.68

1.4

1.6

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

259

2.12

6.64

1.0

1.2

39.01

45.93

mg/l

1.71

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

285

1982

1.39

6.62

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

225

1504

1.45

6.54

1.7

1.9

149.23

136.04

1.81

214

1416

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

227

1521

1.44

6.51

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3877

34448

1.10

6.49

1.5

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

102

2.84

6.48

1.1

1.4

590.68

484.56

nmol/l

0.43

102

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

167

1060

1.52

6.29

1.1

97.24

91.21

1.85

488

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

209

2.22

6.23

1.4

1.3

1.00

1.66

ml/s/173m2

0.83

139

(3026470) Cobalt [Mass/volume] in Blood

196

1294

1.46

6.11

2.0

4.71

3.25

ug/l

1.28

176

1189

(3019897) Erythrocyte distribution width [Ratio] by Automated count

399

4962

0.77

6.04

3.4

2.4

13.48

13.12

8.21

394

4899

(3016038) Potassium [Moles/volume] in Urine

217

1465

1.43

6.02

1.1

1.2

31.30

34.45

mmol/l

1.39

178

1269

(40762814) Titanium [Mass/volume] in Blood

357

1.89

5.97

2.2

2.4

3.77

3.95

ug/l

0.09

127

(3047189) Immunofixation for 24 hour Urine

159

1013

1.52

5.92

1.5

1.9

—

(3018133) Calcium [Moles/volume] in Urine

421

1.81

5.88

2.0

1.9

2.92

2.58

mmol/l

0.66

382

(3023199) Leukocytes [#/volume] in Pleural fluid

331

2412

1.33

5.77

1.6

1.5

3226.30

3570.02

e6/l

0.10

247

1734

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

239

1656

1.39

5.75

1.6

1.4

6.31

5.84

u/l

0.30

208

1388

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

257

1804

1.38

5.72

1.4

1.3

444.84

525.85

u/l

0.60

242

1718

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

101

583

1.67

5.70

1.4

1.6

0.43

0.38

ug/l

0.70

397

(3025577) Chromium [Mass/volume] in Blood

190

1266

1.45

5.68

2.1

2.42

2.29

ug/l

0.15

150

1067

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

491

1.73

5.63

1.2

1.4

0.21

0.28

nmol/l

0.98

355

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

306

2214

1.34

5.61

1.1

1.3

2.11

2.01

mmol/l

0.53

284

2065

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

157

2.34

5.61

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

157

1012

1.50

5.56

1.1

1.0

5.83

11.33

u/ml

4.28

591

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

565

4424

1.24

5.55

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

104

611

1.64

5.51

7.7

8.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.08

5.49

1.4

1.2

—

(3035880) pH of Pleural fluid

163

1062

1.48

5.48

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

390

2929

1.29

5.47

1.4

1.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

467

1.74

5.45

1.5

1.4

25.35

23.94

0.17

390

(3028433) Virus identified in Specimen by Culture

143

909

1.52

5.42

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

556

4361

1.23

5.39

1.8

2.0

2.50

7.82

titre

—

103

(3042301) Urate [Moles/volume] in Synovial fluid

3.77

5.39

1.0

502.33

355.19

umol/l

—

(3023383) Lactate [Moles/volume] in Pleural fluid

100

588

1.64

5.29

1.3

3.58

3.54

mmol/l

0.04

540

(3017704) Immunofixation for Urine

180

1209

1.44

5.20

1.2

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

327

2417

1.31

5.20

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

121

2.47

5.19

1.0

0.14

0.06

u/ml

0.36

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

105

629

1.61

5.17

1.3

36.72

40.54

0.41

430

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

164

1086

1.46

5.12

1.1

1.2

119.98

109.33

2.86

150

980

(3010375) cycloSPORINE [Mass/volume] in Blood

186

1263

1.42

5.08

28.1

28.3

116.58

118.91

ug/l

0.16

152

1050

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

156

1026

1.47

5.05

2.8

2.4

144.70

152.45

nmol/l

0.49

138

897

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

493

1.68

5.04

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

180

2.14

4.87

1.5

1.2

23.78

21.35

mmol/l

1.76

134

(3047007) Chlamydophila sp Ab [Presence] in Serum

574

4569

1.22

4.87

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

385

2935

1.27

4.85

3.0

3.3

5.21

7.79

nmol/l

0.68

357

2847

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3034

27021

1.09

4.84

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

388

2963

1.27

4.82

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

342

1.81

4.80

2.5

2.6

75.07

59.97

pmol/l

0.37

290

(3000919) Neutrophils/100 leukocytes in Pleural fluid

515

1.65

4.79

1.3

1.4

27.50

22.26

0.88

471

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

113

703

1.55

4.78

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

717

5842

1.19

4.74

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

156

1040

1.45

4.74

1.1

102.02

92.45

2.26

485

(3001686) Cold agglutinin [Titer] in Serum or Plasma

446

1.69

4.65

1.2

1.4

21.71

174.30

titre

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.59

4.64

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

528

1.63

4.61

1.3

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3959

40770

0.93

4.54

2.8

2.9

0.67

0.74

ug/l

3.69

2609

25866

(40761539) Cells [Type] in Urine sediment by Light microscopy

102

628

1.57

4.54

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

483

3808

1.23

4.54

2.3

2.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

167

1140

1.41

4.48

2.5

2.4

52.48

50.99

umol/l

0.21

140

990

(3051339) Copper [Moles/volume] in Blood

144

2.21

4.37

1.3

17.67

16.48

umol/l

0.68

125

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

373

2875

1.25

4.33

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

160

1092

1.42

4.32

2.3

2.7

159.33

151.01

au/ml

0.09

162

(21491868) Cryoglobulin [Mass/volume] in Serum

145

972

1.44

4.32

1.2

0.14

0.59

g/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

167

1151

1.40

4.27

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

293

2200

1.29

4.23

1.6

1.5

76070.12

48803.35

e6/l

0.81

173

1306

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

104

657

1.53

4.17

1.5

2.0

34.54

34.14

u/l

0.01

587

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

275

2053

1.29

4.16

1.3

1.4

12.99

11.56

umol/l

2.53

252

1961

(3011436) Histone Ab [Units/volume] in Serum

583

1.56

4.09

1.1

—

36.88

u/ml

—

(3029612) Listeria sp Ab [Titer] in Serum

2.72

4.08

1.2

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2392

21248

1.09

4.08

1.8

—

(37019676) Renin [Units/volume] in Plasma --supine

3.09

4.06

1.0

1.1

103.37

64.90

mu/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

564

1.56

3.99

1.3

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

188

1340

1.36

3.95

2.0

2.1

200.79

198.44

u/l

0.21

188

1331

(3038071) Oxygen [Partial pressure] in Mixed venous blood

543

1.56

3.94

7.9

8.9

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

160

1113

1.39

3.91

1.8

1.9

174.62

156.29

1.24

152

1050

(3042517) Benzodiazepines panel - Urine

395

1.66

3.89

2.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

170

1197

1.37

3.87

2.7

3.2

7.73

8.13

mg/l

0.29

133

955

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

241

1791

1.30

3.81

1.8

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

184

1316

1.35

3.80

36.2

7.34

7.38

ug/l

0.10

164

1200

(3010726) Horse dander IgE Ab [Units/volume] in Serum

689

5715

1.17

3.76

1.1

1.45

2.02

u/ml

1.18

380

2764

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.91

3.70

1.9

2.2

2.49

2.25

mu/l

0.09

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

181

1.97

3.70

1.0

1.2

29.86

21.63

—

(3036782) Glucose [Moles/volume] in Pleural fluid

260

1962

1.28

3.67

1.3

6.88

6.23

mmol/l

3.07

237

1813

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.62

3.64

1.0

1.2

1524.80

4043.40

ng/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

442

3540

1.21

3.64

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.47

3.59

1.0

1.1

187.67

225.67

pmol/l

0.26

(3011325) HIV 1+2 Ab [Presence] in Serum

144

2.08

3.57

1.1

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

144

2.08

3.57

1.1

1.3

—

303.33

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

391

1.63

3.53

1.3

1.5

535853.53

190861.30

nmol/l

0.55

328

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

113

2.22

3.53

1.0

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.51

3.52

1.7

1.5

266.67

249.38

nmol/l

0.05

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

315

2446

1.24

3.52

1.0

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

195

1426

1.32

3.50

1.3

12.99

14.71

u/l

0.70

181

1319

(3038177) Helicobacter pylori Ab [Presence] in Serum

625

5180

1.17

3.48

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

104

685

1.47

3.48

1.3

1.4

59.55

61.24

0.19

566

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1010

8659

1.13

3.46

2.9

3.6

1102.11

2087.87

u/ml

0.48

844

7440

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

132

910

1.40

3.46

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

372

1.63

3.43

1.2

1.60

1.78

mmol/l

0.43

221

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5733

57842

0.95

3.43

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

578

1.50

3.42

1.3

1.4

1.52

2.97

1.89

488

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.59

3.39

1.9

1.5

153.90

327.47

nmol/l

—

(1175426) CD3 cells/100 lymphocytes in Blood

289

2235

1.25

3.36

1.7

2.1

73.93

73.43

0.24

283

2142

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

333

2616

1.23

3.36

1.1

1.2

43.13

41.69

mg/l

0.20

287

2175

(1617658) Protocol used for examination of sentinel lymph nodes

169

2154

0.76

3.29

1.0

—

(3048879) Bone marrow aspiration report

640

1.46

3.25

1.3

2.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

322

2533

1.23

3.22

1.0

1.1

238.38

256.68

mg/l

0.87

283

2219

(3027231) Wheat IgE Ab [Units/volume] in Serum

650

1.46

3.20

1.1

1.24

3.75

u/ml

0.78

544

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

201

1498

1.30

3.19

1.1

1643.81

1491.88

miu/ml

1.05

201

1498

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

589

1.48

3.15

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

708

1.43

3.15

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

243

1.75

3.09

1.4

1.2

5.56

6.23

mmol/l

0.30

117

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

105

711

1.43

3.09

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.81

3.08

1.1

1.0

0.02

0.09

g/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

354

2831

1.21

3.04

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

446

1.54

3.03

1.1

1.4

74.82

298.55

ng/l

0.60

276

(3011412) CD3 cells [#/volume] in Blood

352

2816

1.21

3.01

2.1

2.4

1.36

1.19

e9/l

3.37

318

2509

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

118

1558

0.73

2.96

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

204

1.80

2.95

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

197

1.81

2.94

1.0

0.04

0.63

u/ml

2.25

180

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

366

1.58

2.92

1.3

59.27

53.16

0.41

179

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

397

1.56

2.90

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

292

1.65

2.89

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

153

1115

1.32

2.89

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

657

1.43

2.87

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

421

1.54

2.87

1.8

39.33

45.01

pmol/l

0.28

357

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

236

1823

1.25

2.84

1.5

—

(3027874) Urate [Moles/volume] in Urine

2.35

2.81

1.1

1.22

1.76

mmol/l

—

(40757373) Influenza virus identified in Isolate

478

1.49

2.80

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

149

1088

1.32

2.79

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

208

1588

1.26

2.78

1.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

341

1.58

2.76

8.3

6.5

—

(3012441) Differential panel - Pleural fluid

266

2090

1.23

2.76

1.6

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

263

2064

1.23

2.76

2.2

2.6

544.81

512.59

e6/l

0.58

225

1727

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

100

2.12

2.74

1.1

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

350

2830

1.19

2.71

3.9

4.8

136.60

108.81

u/ml

0.30

107

920

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

171

1279

1.29

2.70

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

240

1870

1.24

2.70

1.6

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

147

1078

1.32

2.69

1.7

2.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

1340

1.28

2.68

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

577

4862

1.15

2.67

2.7

3.5

683.43

839.12

u/ml

0.21

523

4416

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

240

1.69

2.66

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

164

1223

1.29

2.66

1.1

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

262

2065

1.23

2.65

1.5

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

301

2406

1.21

2.65

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

301

2409

1.21

2.62

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.12

2.60

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

249

1.67

2.60

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

300

2404

1.21

2.58

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.37

2.58

10.4

8.5

—

(3025130) Human papilloma virus identified in Specimen

477

5311

0.86

2.58

1.6

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

184

1400

1.27

2.56

1.2

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

255

2013

1.22

2.56

2.2

2.6

0.24

0.23

e9/l

0.51

225

1732

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

356

1.55

2.55

1.8

3.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1120

11841

0.91

2.53

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1121

11847

0.91

2.51

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

133

973

1.32

2.50

2.4

3.0

30.37

28.40

umol/l

0.91

755

(3000219) Insulin receptor Ab [Presence] in Serum

6.89

2.48

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7493

70010

1.04

2.48

4.4

4.6

2.16

2.82

ug/l

1.94

6615

63504

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

302

2434

1.20

2.46

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

118

1.96

2.46

1.1

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1116

11782

0.91

2.46

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

533

1.43

2.45

1.1

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

188

1.75

2.44

1.1

0.39

1.33

u/ml

0.96

132

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.10

2.44

1.1

0.87

1.39

u/field

0.80

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.25

2.44

1.1

—

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1120

11817

0.91

2.44

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

301

2429

1.20

2.43

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.46

2.42

1.1

0.05

0.21

g/l

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.46

2.42

1.3

1.0

1.00

1.25

u/field

0.40

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

301

2431

1.20

2.41

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

211

1.69

2.39

1.5

1.4

7.40

14.04

pmol/l

1.34

175

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

362

1.52

2.39

1.1

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

148

1107

1.29

2.39

1.9

2.0

7.05

9.55

mg/l

7.27

120

889

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

137

1016

1.30

2.36

1.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

339

2774

1.18

2.35

1.8

2.0

26.01

24.15

ug/l

0.18

329

2713

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2742

25030

1.06

2.34

3.3

4.1

27.09

23.68

ug/l

0.23

2170

19739

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

227

1790

1.22

2.34

1.1

1.18

1.05

u/l

0.40

101

793

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

572

4877

1.13

2.28

1.1

18.29

10.57

au/ml

0.63

342

(3010503) CD19 cells [#/volume] in Blood

215

1693

1.23

2.26

2.4

2.6

0.20

0.27

e9/l

0.62

207

1652

(3029075) Extractable nuclear Ab panel - Serum

125

922

1.31

2.26

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.92

2.25

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

360

1.50

2.24

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

291

1.56

2.23

1.3

1.2

0.70

1.36

mmol/l

1.04

184

(3003157) Bacteria [#/volume] in Mother's milk

2.21

2.22

4.3

7.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

158

1.77

2.21

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

284

1.56

2.21

1.0

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

109

1383

0.76

2.19

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.52

2.19

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

538

1.40

2.18

1.4

1.3

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

3.75

2.17

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

355

1.50

2.17

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1103

11575

0.92

2.17

2.1

1.9

—

(40768806) Pleura Pathology biopsy report

260

2096

1.20

2.17

1.6

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

167

1.73

2.14

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

627

5404

1.12

2.12

1.6

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.10

2.11

1.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

469

1.42

2.10

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

617

1.36

2.07

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

709

1.33

2.06

1.1

—

(3034426) Prothrombin time (PT)

140

1065

1.27

2.03

1.3

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

284

2324

1.18

2.02

1.5

1.3

23.25

32.56

nmol/l

8.86

247

2149

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

703

1.33

2.02

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

149

1.75

2.00

1.0

1.1

37.59

59.92

u/l

1.20

119

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.16

2.00

1.0

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

238

1.58

1.99

1.3

22.68

26.04

0.27

183

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

410

1.44

1.99

6.3

7.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

713

1.33

1.99

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.21

1.97

11.7

8.1

45.11

46.67

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

539

4629

1.13

1.96

1.1

5.58

4.91

u/ml

0.21

231

1878

(3011335) Digoxin [Mass/volume] in Serum or Plasma

150

1.74

1.96

2.4

2.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

150

1.74

1.96

1.0

1.2

1.10

1.24

u/field

0.39

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

100

732

1.32

1.95

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

1062

0.74

1.95

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

278

1.53

1.95

1.2

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

115

1.85

1.94

1.5

0.00

0.04

u/l

0.49

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

341

1.47

1.93

1.8

1.6

1.97

1.58

mg/l

0.88

282

(3005011) Chlamydia sp Ab [Titer] in Serum

429

1.42

1.93

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

223

1796

1.20

1.92

2.0

1.6

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

359

1.45

1.88

1.0

0.02

0.21

u/ml

2.55

215

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

775

6806

1.10

1.88

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

296

1.50

1.88

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

118

889

1.28

1.88

2.8

3.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.32

1.87

1.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

235

1.56

1.86

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

222

1.56

1.79

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.00

1.79

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

534

1.36

1.79

1.1

—

(3019174) dRVVT (LA screen)

284

1.50

1.79

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

292

1.49

1.78

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

669

1.31

1.76

1.1

1.2

68.92

75.80

0.33

172

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

669

1.31

1.76

1.1

1.2

102.53

86.14

1.75

178

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

178

1.63

1.75

1.2

1.1

8.87

9.83

u/l

0.13

178

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1216

12577

0.93

1.73

1.5

—

(40758358) Immune stain study

120

1.77

1.72

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

295

1.47

1.71

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

851

1.27

1.70

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

253

2087

1.17

1.70

1.8

2.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

115

881

1.26

1.64

1.4

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

362

1.41

1.64

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

462

3985

1.12

1.63

1.1

1.0

0.25

0.41

u/ml

0.97

153

1002

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

117

901

1.25

1.61

1.8

1.7

188.49

125.81

au/ml

0.68

105

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

170

1965

0.83

1.60

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

348

1.41

1.60

1.0

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

316

1.44

1.59

2.8

3.4

37.16

42.63

umol/l

1.07

271

(4212803) Bone marrow aspirate examination

191

1.57

1.58

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

437

3766

1.12

1.57

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

563

4924

1.10

1.55

1.1

5.02

4.32

u/ml

0.27

283

2278

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

326

1.42

1.55

1.0

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

223

1.51

1.55

1.0

1.82

0.88

u/ml

0.21

142

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

319

1.42

1.53

1.0

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

225

1.50

1.49

1.1

—

2.64

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.86

1.49

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

145

1155

1.21

1.48

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

145

1155

1.21

1.48

1.6

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

273

1.45

1.48

1.6

0.59

1.98

mg/l

4.00

175

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

162

1307

1.20

1.45

1.2

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

219

1.50

1.45

1.2

14.54

15.92

nmol/l

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.35

1.44

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.12

1.44

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

173

1.56

1.43

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.03

1.42

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

268

1.44

1.41

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

519

5501

0.91

1.39

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

253

1.45

1.39

1.4

1.3

82.03

332.22

u/l

0.76

186

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

335

1.38

1.36

1.0

0.16

1.51

u/ml

0.64

176

(3037692) Legionella sp identified in Specimen by Organism specific culture

115

908

1.22

1.32

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

177

1455

1.17

1.31

1.3

57.60

66.06

0.51

172

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

169

1385

1.18

1.30

1.5

1.6

1897160.08

1816803.82

iu/ml

0.02

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

178

1.52

1.29

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

140

1.59

1.27

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

721

1.24

1.27

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

939

1.21

1.26

1.8

1.7

4029.93

32049.70

u/ml

1.13

115

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

550

1.28

1.26

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

0.79

2.12

mg/l

2.53

157

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

0.36

0.96

mg/l

1.89

177

(3032868) Hemoglobin electrophoresis panel in Blood

267

1.41

1.25

1.6

1.5

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

2.66

2.02

mg/l

0.26

194

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

1.98

1.62

mg/l

0.27

188

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

1.13

2.33

mg/l

1.68

173

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

2.98

3.87

mg/l

0.40

168

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

1.24

2.70

mg/l

1.35

184

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

1.92

2.44

mg/l

0.34

182

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

267

1.41

1.25

1.6

0.81

1.18

mg/l

0.48

164

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

156

1.55

1.25

1.3

1.7

185.53

178.50

ug/g

0.07

132

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.02

1.24

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

246

2085

1.14

1.23

1.2

1.1

—

(36303858) Crystals [Presence] in Urine

2.20

1.23

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

370

3216

1.11

1.22

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

423

3704

1.10

1.21

1.7

4928.00

3322.11

titre

—

133

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

538

1.27

1.19

1.4

1.2

328.87

319.03

ug/l

0.01

291

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

114

911

1.21

1.19

1.3

1.2

23.40

20.47

0.14

156

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.72

1.19

1.1

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

328

1.35

1.18

1.0

0.09

0.37

u/ml

0.85

183

(3011897) Casein IgE Ab [Units/volume] in Serum

539

1.27

1.18

1.1

1.2

0.22

1.72

u/ml

1.15

532

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.54

1.16

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

178

1486

1.16

1.13

1.7

2.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

307

1.35

1.11

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

130

1.56

1.11

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

391

1.31

1.10

1.9

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

258

1.38

1.10

1.3

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

366

1.32

1.10

1.4

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

727

1.22

1.09

1.0

1.1

6.28

6.48

mg/g

0.16

689

(3017958) Strawberry IgE Ab [Units/volume] in Serum

100

1.64

1.09

1.0

0.01

0.07

u/ml

1.49

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

100

1.64

1.09

1.1

1.3

0.75

1.18

u/field

1.30

(40758292) HTLV I+II Ab panel - Serum

485

0.74

1.08

1.1

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

228

1.40

1.04

1.1

1.0

0.08

0.77

u/ml

3.36

125

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

212

1.41

1.04

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.05

1.02

1.0

1.2

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

2.19

0.98

1.2

1.4

66.76

73.67

nmol/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

158

1.47

0.98

1.1

1.0

—

(40768795) Lymph node Pathology biopsy report

248

2668

0.90

0.98

1.1

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

676

1.21

0.98

2.6

85.01

106.07

ng/l

0.67

355

(3045683) HLA typing for celiac disease panel - Blood or Tissue

230

1979

1.12

0.97

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

477

1.25

0.97

2.1

4.8

52.90

68.38

u/l

0.64

468

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.93

0.96

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.93

0.96

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.93

0.96

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.93

0.96

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.93

0.96

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.93

0.96

2.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

286

2494

1.11

0.95

1.9

2.2

43.69

39.08

6.07

278

2452

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

200

1.40

0.95

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

308

1.32

0.94

1.0

0.02

0.54

u/ml

2.46

178

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

230

1983

1.12

0.94

1.6

1.9

4.60

3.43

mg/l

2.87

216

1898

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

144

1.47

0.94

1.2

1.3

1.36

1.69

mg/l

0.69

120

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

0.50

0.93

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

135

1126

1.16

0.92

1.1

468.45

492.32

ng/l

0.04

257

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

472

1.25

0.92

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

293

1.32

0.91

1.3

13.10

13.82

0.05

153

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.14

0.91

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

227

1.36

0.90

1.3

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

178

1.41

0.89

3.2

5.1

—

(3049233) Organic acids panel - Urine

2.07

0.89

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

139

1.46

0.86

3.1

3.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2016

18798

1.04

0.85

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.57

0.85

1.1

256.07

247.17

nmol/l

0.06

(3000060) B lymphocytes [#/volume] in Blood

108

892

1.17

0.85

1.6

2.2

279.54

577.73

e6/l

0.51

484

(3011841) English Walnut IgE Ab [Units/volume] in Serum

323

1.28

0.84

1.0

4.96

1.39

u/ml

0.32

241

(3012989) Citrate [Moles/time] in 24 hour Urine

1.75

0.83

2.6

1.2

2.18

2.32

mmol/24h

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.65

0.82

1.0

142.50

399.60

u/l

1.27

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

111

0.52

0.82

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

207

1.35

0.80

1.7

1.4

26.00

35.63

0.60

136

(3035933) Granulocytes/100 leukocytes in Blood

883

0.84

0.80

1.4

1.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

141

1196

1.14

0.79

1.7

2.2

11.15

9.88

0.60

136

1107

(3009992) Blasts/100 cells in Bone marrow

0.00

0.79

0.0

1.8

—

15.67

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.78

0.0

1.5

—

(3022475) Manganese [Moles/volume] in Blood

204

0.66

0.78

1.1

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

571

1.20

0.78

1.1

0.40

3.39

u/ml

1.93

407

(3047185) IgG [Mass/volume] in Urine

1.66

0.77

1.1

1.0

—

45.20

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

218

1.33

0.75

1.1

19.87

23.04

u/l

0.54

145

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

207

1805

1.11

0.75

5.8

6.7

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

252

2658

0.91

0.74

3.6

3.8

44.92

44.65

u/ml

0.01

244

2638

(21494434) Karyotype in Bone marrow

226

1983

1.10

0.73

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

239

2103

1.10

0.72

1.1

0.63

2.93

u/ml

1.84

661

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

207

2201

0.91

0.72

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

102

853

1.15

0.72

1.8

2.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.61

0.72

2.4

2.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

178

1.35

0.72

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

536

0.81

0.71

1.8

2.4

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

1.73

0.70

1.0

0.10

0.13

u/ml

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

171

1.35

0.69

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.53

0.68

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

282

1.27

0.68

1.2

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

106

1.46

0.68

5.8

9.7

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.64

0.67

2.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

523

5344

0.94

0.67

1.1

—

(3015183) Erythrocyte sedimentation rate

192

1683

1.10

0.65

1.3

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

216

1.30

0.64

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.57

0.64

2.1

4.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

524

5340

0.95

0.63

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

217

1.29

0.62

2.0

2.7

24.07

60.07

pmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

287

1.24

0.61

1.2

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.60

0.0

1.1

—

(3014891) Appearance of Pleural fluid

244

1.27

0.60

1.3

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

176

1.32

0.60

1.3

1.4

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.54

0.59

1.8

1.1

67.13

75.40

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.54

0.59

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

211

1.28

0.58

1.0

0.06

1.91

u/ml

1.67

162

(3006598) pH of Arterial cord blood

1.46

0.57

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

489

0.83

0.57

2.8

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

488

0.83

0.56

5.7

6.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

155

1640

0.91

0.54

2.4

2.7

44.10

39.66

2.51

105

904

(3015350) Toxocara sp Ab [Presence] in Serum

1.56

0.54

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

319

1.21

0.53

2.3

2.2

0.77

0.61

u/field

0.48

319

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

197

1.27

0.53

1.0

1.1

16.80

15.76

iu/ml

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.52

0.52

2.2

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

453

1.17

0.52

1.0

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

138

1.33

0.52

1.1

1.2

—

14403.14

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

204

1820

1.08

0.51

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

293

0.79

0.51

1.9

2.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

116

1008

1.11

0.51

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

184

0.73

0.50

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

139

1.32

0.50

1.8

1.6

0.69

0.71

umol/l

0.07

105

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

234

2104

1.07

0.49

2.4

2.6

855.91

673.75

e6/l

5.45

224

2042

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

123

1.33

0.48

1.2

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

123

1.33

0.48

1.2

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

1.38

0.48

1.2

1.4

676.07

964.35

nmol/l

0.63

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

149

1.29

0.47

1.1

1.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.62

0.45

1.0

1.1

—

(3013862) HLA-DP [Type]

113

0.68

0.45

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

370

1.17

0.45

1.1

1.0

—

(3007733) Chloride [Moles/volume] in Urine

1.46

0.45

1.1

1.5

78.70

90.04

mmol/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

460

1.15

0.45

1.1

1.4

—

(3018291) Platelet Ab [Presence] in Serum

1.41

0.45

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

180

0.75

0.44

2.7

5.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

111

974

1.10

0.43

1.2

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

117

1.32

0.43

1.2

1.1

36.99

36.07

0.42

109

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

117

1.32

0.43

1.2

1.1

20.44

21.38

0.38

107

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

117

1.32

0.43

1.1

8.43

8.70

0.20

107

(3004446) Plasmodium sp identified in Blood by Light microscopy

355

1.17

0.42

2.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.64

0.42

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.56

0.42

2.0

2.5

—

(3009871) Measles virus Ab [Titer] in Serum

122

1078

1.09

0.42

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

229

2076

1.06

0.41

1.1

0.73

4.16

u/ml

1.42

487

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

384

1.16

0.40

1.1

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.39

0.0

1.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

171

1.24

0.39

1.0

—

(3022670) pH of Venous cord blood

1.31

0.39

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

427

0.86

0.39

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

278

1.18

0.38

1.1

2.23

1.65

umol/24h

1.77

278

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

626

5832

1.04

0.38

1.3

3.61

3.58

ug/l

0.04

569

5273

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

175

0.77

0.38

6.2

4.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

305

1.17

0.38

1.6

2.0

7.16

7.17

mmol/l

0.01

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

596

1.12

0.37

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

596

1.12

0.37

1.2

1.1

—

(40760410) HLA-B [Type] by High resolution

109

0.71

0.37

1.0

—

(40760409) HLA-A [Type] by High resolution

109

0.71

0.37

1.0

—

(46236302) HLA-C [Type] by High resolution typing

110

0.70

0.37

1.0

—

(40763590) HLA-DQ beta [Type]

110

0.70

0.37

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

182

1.22

0.36

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.45

0.35

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.45

0.35

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

236

0.82

0.35

2.8

3.6

2.10

2.21

mg/l

0.08

204

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

326

1.15

0.35

1.0

3.54

1.32

u/ml

0.29

243

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

299

1.16

0.35

1.2

1.4

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

131

1.25

0.33

1.0

—

(3020650) Glucose [Presence] in Urine

833

1.09

0.33

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

114

1.27

0.33

14.9

16.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

167

1.21

0.32

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

191

0.81

0.32

1.0

1.1

0.67

10.42

u/ml

0.48

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

596

1.10

0.31

1.2

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

137

0.77

0.30

1.1

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.27

0.30

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

199

0.82

0.29

1.4

2.4

—

(3013762) Body weight Measured

105

0.73

0.29

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.23

0.29

1.4

1.1

2.57

2.44

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

155

1583

0.94

0.28

1.0

236.79

333.91

ng/l

3.46

114

1141

(3003338) MCHC [Mass/volume]

25940

250742

0.99

0.28

24.5

15.4

330.10

332.84

g/l

307.65

25767

249000

(3041672) Baker's yeast Ab [Presence] in Serum

166

0.81

0.27

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

654

0.91

0.27

1.1

1.3

—

(3034614) HLA Ag [Interpretation]

1.30

0.26

1.0

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

334

3113

1.04

0.24

1.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.29

0.24

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

157

1591

0.95

0.24

1.0

31.94

42.16

ng/l

4.23

114

1126

(3018001) Oat IgE Ab [Units/volume] in Serum

245

0.87

0.23

1.0

0.05

0.81

u/ml

1.17

146

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

157

1589

0.95

0.23

1.0

883.42

739.52

ng/l

3.27

112

1105

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(4035726) Immunohistochemistry procedure

2374

23145

0.99

0.21

1.4

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.3

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

158

1.16

0.20

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

509

1.08

0.20

4.3

5.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

413

0.91

0.20

1.2

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

107

0.81

0.20

1.9

3.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

186

1.14

0.19

1.3

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

909

0.94

0.19

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

141

1.16

0.19

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

189

0.87

0.18

1.2

0.15

5.84

u/ml

1.94

158

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.16

0.17

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.14

0.17

2.4

5.5

—

(3030313) Adrenal Ab [Titer] in Serum

336

1.09

0.17

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

125

1.16

0.16

1.4

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

101

1020

0.95

0.16

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

199

1.11

0.15

1.0

10.43

17.00

u/ml

0.61

166

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.75

0.15

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.16

0.15

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

686

1.05

0.15

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

686

1.05

0.15

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

686

1.05

0.15

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

686

1.05

0.15

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

563

0.94

0.14

1.7

1.9

1.94

3.54

ug/l

0.90

337

(3015076) Soybean IgE Ab [Units/volume] in Serum

192

1906

0.97

0.14

1.1

1.0

0.39

1.01

u/ml

0.92

431

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

103

0.84

0.13

1.9

3.3

—

(3026726) Creatinine [Moles/volume] in Specimen

211

1.10

0.13

2.5

242.58

407.02

umol/l

0.96

204

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

559

1.05

0.12

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

259

1.08

0.11

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

166

1.10

0.11

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

503

4785

1.01

0.11

1.1

3.37

2.87

u/ml

0.30

209

2435

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

176

1.10

0.10

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

421

1.05

0.10

2.1

2.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

160

0.90

0.09

1.0

0.09

9.35

u/ml

—

(40765096) Chromosome analysis panel by Banding

700

0.96

0.09

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.83

0.08

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.83

0.08

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

532

0.96

0.08

1.5

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.83

0.07

1.3

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.84

0.07

4.3

3.0

—

(3045142) Bone marrow Pathology biopsy report

273

2668

0.99

0.07

1.2

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

314

0.95

0.06

2.8

2.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

186

0.93

0.06

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

106

1.09

0.05

1.1

1.2

0.06

0.08

g/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

204

0.95

0.05

1.0

1.1

9.19

6.68

u/ml

—

151

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

212

2025

1.01

0.04

1.4

1.3

123.01

173.75

pmol/l

4.34

212

2025

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

105

0.92

0.03

1.5

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.08

0.03

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

184

1.05

0.03

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

114

0.93

0.03

1.1

1.0

0.23

0.53

u/ml

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

118

1.06

0.02

1.1

1.0

0.09

0.31

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

481

0.98

0.01

3.1

2.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

159

1524

1.01

0.01

1.1

—

(3007463) Buprenorphine [Presence] in Urine

148

1.04

0.01

8.6

7.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

199

0.97

0.01

1.9

2.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

189

0.97

0.00

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

143

1373

1.00

0.00

5.7

5.9

4386.89

3035.09

u/ml

0.11

273

(3013293) Extractable nuclear Ab [Presence] in Serum

467

1.01

0.00

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

109

0.97

0.00

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

282

0.99

0.00

2.7

3.0

1.47

1.17

mg/l

0.30

189

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

383

1.01

0.00

2.0

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

289

1.00

0.00

1.3

—

(3008607) Semen analysis panel

133

1.02

0.00

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

124

1200

1.00

0.00

3.2

3.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.00

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.0

—

141.00

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.95

-0.00

1.0

1.2

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.3

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

9.4

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

0.52

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

571.80

—

(3012864) Amino acids [Identifier] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITY and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITY	2.165 [1.95, 2.41]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.088

During the follow-up period (1.1.1998 — 31.12.2019), 8290 out of 89525 females with E4_OBESITY died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITY	2.128 [1.93, 2.35]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 9824 out of 62365 males with E4_OBESITY died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITY.

N-year risk	Females	Males
1	0.18%	0.361%
5	1.077%	2.149%
10	2.722%	5.613%
15	5.357%	10.93%
20	9.317%	18.155%

Relationships between endpoints

↥

Index endpoint: E4_OBESITY – Obesity

GWS hits: 85

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints